CELLETS® 100

(100-200 µm)

CELLETS® 100 is a subtype of pellets made of microcrystalline cellulose. The size ranges from 100 µm to 200 µm. Find more product information and technical specifications.

Revealing the physical restrictions of caecal influx in broilers through the use of solid and soluble markers

Paulien Vanderghinste, An Bautil, Michael R. Bedford, Gemma González-Ortiz, Chris Lamberigts, Imran Aslam, Maarten Roeffaers, Christophe M. Courtin

Abstract

A promising strategy to support broiler health and performance in a sustainable way is the enhancement of microbial fibre fermentation in broilers. This fermentation mainly occurs in the caeca, but the actual particle size range that allows caecal influx has not yet been described. This study aimed to understand the physical limitations of caecal influx as a function of broiler age by using both solid and soluble markers. In the first trial, the caecal filter mechanism was studied by microscopically visualising the caecal entrance and measuring caecal lobe development and digesta particle size as a function of age (d 8 to 36) for 44 broilers (Ross 308) receiving a conventional wheat-based diet. In two consecutive trials, microcrystalline cellulose beads (100 to 700 μm) and a combination of fluorescent polystyrene beads (5 to 30 μm) and chromium-ethylenediamine tetraacetic acid (Cr-EDTA) were administered to 176 and 189 broilers, respectively, at different ages (d 8 to 36). Results showed that the actual caecal entrance diameter is significantly reduced due to a dense villi network acting as a filter for digesta inflow. This explains the size gap between the average digesta particle size (D50) of the ileum (451 to 322 μm), caeca (5 to 19 μm) and the outer diameter of the caecal entrance (2000 to 4000 μm) on d 8 to 36. In contrast to the caecal D50, cellulose beads of 700 μm already entered the caeca at 8 d of age, even though the general caecal influx of digesta particles larger than 100 μm seemed very limited. The caecal influx of the markers further exhibited large individual variation among birds. A maximum of 13.2% (d 9) and 4.3% (d 29) of the total administered soluble marker (Cr-EDTA) was detected in the caeca, 5 h after bolus administration. Both solid and soluble markers showed a larger concentration in the caeca at a young age compared to older ages (P < 0.01), possibly related to the limited caecal functioning early in life. These findings highlight the importance of carefully selecting the physical properties of fibres to be added as a function of age to further improve caecal fibre fermentation in broilers.

1. Introduction

Broiler production is in need of sustainable and cost-effective solutions to maintain the high performance and health status of broilers without the use of in-feed antibiotics. A promising strategy to improve gut health and performance is enhancing dietary fibre (DF) fermentation. Although DF is mainly known for its adverse effects on broiler performance due to its undigestible and antinutritional characteristics, more recent studies also show the potential beneficial effects of DF on health and performance (Kheravii et al., 2017; Pourazadi et al., 2020; Vermeulen et al., 2017). Even though these effects are still not completely understood, they seem to depend on the particle size and solubility of the DF addition. Coarse insoluble DF inclusions (> 1000 μm) can act as structural components in broiler diets, which can enhance gizzard functionality and retention time in the upper part of the gastrointestinal tract (GIT). As a result, increased nutrient utilisation and performance can be observed (Donadelli et al., 2019; Kheravii et al., 2017, 2018; Lentle et al., 2006, Pourazadi et al., 2020). In addition, DF fractions can be solubilised and subsequently fermented by microbiota in the broiler’s hindgut, resulting in the production of short-chain fatty acids. These short-chain fatty acids can act as an additional energy source for the broiler and can stimulate the growth of beneficial microbiota, as well as control the growth and expression of invasive genes of pathogenic bacteria. Providing more substrate suitable for beneficial fibre-fermenting bacteria by increasing the fermentable DF content in broiler diets can result in an additional decrease of pathogenic bacteria in the GIT by competitive exclusion (Singh & Kim, 2021; Vermeulen et al., 2017).
Most microbial fermentation of DF in poultry occurs in the caecal lobes, which are two blind sacs located at the junction of the ileum and colon. It is hypothesised that the digesta inflow into these lobes is restricted to very small particles, solutes and fluids, although no exact cut-off in particle size has been described (Svihus et al., 2013). The marked restriction of material that enters the caeca was illustrated by Son et al. (2002), who showed that only 18% of the total excreted dry matter and 17% of the total excreted water passed through the caeca. Several studies using digestibility and transit time markers provide an indication of the physical limitations of caecal influx and illustrate the vast difference between the influx of solid and soluble markers. Ferrando et al. (1987) observed that 500 to 2000 μm fibre particles could not enter the caeca in 8- to 10-week-old broilers, but 9% to 26% of the soluble marker chromium-ethylenediamine tetraacetic acid (Cr-EDTA) did enter the caeca in 1- to 3-week-old broilers in a separate experiment by this research group (Vergara et al., 1989). Similarly, Garçon et al. (2023) described a caecal inflow from 30% to 35% of the soluble digesta fraction in 25-day-old broilers based on the use of the soluble marker cobalt (Co)-EDTA. De Vries et al. (2014) further observed a minimal caecal influx of CrO3, linked to the solid phase of the diet, in contrast to the abundant presence of the soluble marker Co-EDTA in the caeca in 4-week-old broilers.
Although it has been hypothesised that only small particles and fluids can enter the caeca, it has also been shown that the addition of both coarse and fine fibre particles can alter caecal microbiota composition. The increase in beneficial fibre-fermenting species and the decrease in pathogenic species in the caeca after the inclusion of fine fibre particles (80 to 300 μm) has been described by Boguslawska-Tryk et al. (2015), De Maesschalck et al. (2019) and Vermeulen et al. (2017). The modification of caecal microbiota by including coarse (fibre) particles (557 to 3000 μm) has also been demonstrated by Pourazadi et al. (2020) and Jacobs et al. (2010). It is still unclear whether these fibre particles as such can truly enter, or that only the solubles originating from the DF fraction end up in the caeca and alter the microbiota composition.
A promising strategy to increase the beneficial effects of DF on broiler health and performance is to enhance the microbial fermentation of DF in the caeca. Due to the observed physical limitations of caecal influx and the lack of a known threshold in particle size for caecal entry, a better understanding of the mechanisms of caecal influx is required. It is hypothesised that the marked restriction of the caecal influx of digesta is mainly due to the extensive network of villi present at the caecal entrance (Svihus et al., 2013). Histological research on the caecal lobes in broilers, layers, geese and quail has shown important differences in microstructures, such as villi, between the different sections (proximal, middle and distal). Well-developed villous structures are abundantly present in the proximal part of the caecal lobes, whereas more fold-like structures can be seen in the middle part and little to no folds are present in the distal part (Chen et al., 2002; Majeed et al., 2009; Pandit et al., 2018; Svihus et al., 2013). Based on this trend of extensive villi development towards the opening of the caecal lobes, a dense network of villous structures can be expected at its entrance. This network could be partly responsible for the filtering mechanism at the caecal entrance by acting as a sieve for the ileal digesta (Clench & Mathias, 1999; Fenna & Boag, 1973; Svihus et al., 2013). In our research group, it was observed that caecal lobe weight and the size of the opening increases with broiler age, which could indicate that the particle size threshold for caecal entry also increases with age (Bautil et al., 2021). Research on the effect of age on the mode of action of this caecal filter mechanism and its histological structure in broilers is still very limited.
As outlined above, the actual size range of particles that can enter the caeca has not yet been described. In addition, multiple studies have already shown that both fine (< 300 μm) and coarse (> 1000 μm) fibre additions can affect the composition and metabolic functioning of the caecal microbiota and the resulting fermentation (Boguslawska-Tryk et al., 2015; De Maesschalck et al., 2019; Jacobs et al., 2010; Pourazadi et al., 2020; Vermeulen et al., 2017). It remains, however, unclear if these fibre additions enter the caeca maintaining their initial particle size, or that they affect the caecal functioning through other mechanisms. Hence, the aim of the current study is to acquire a deeper understanding of the physical limitations of caecal influx. This can enable valuable insights to explore new strategies to further increase DF fermentation in poultry.

2. Materials and methods

2.1. Animal ethics statement

The broiler trials were approved by the Ethical Committee for the experimental use of animals of the KU Leuven under accession number P140/2020.

2.2. Broiler Housing, Diets and Sampling

Three consecutive broiler trials were conducted to study the physical limitations of caecal entrance by means of particle size in broilers. In the first part of this research, the size of the digesta particles present in the caeca was quantified for broilers fed a conventional wheat-based diet (control trial). In the second part, solid and soluble inert markers were administered to broilers in two trials to explore the particle size that allows caecal influx as a function of age.
For all three trials, conventional heating, ventilation and lighting conditions for broiler housing were applied (Aviagen, 2018). The housing temperature was set at 34 °C on d 1, gradually decreased to 21 °C at d 27 and thereafter kept constant at this temperature. The light schedule consisted of 23 h light and 1 h darkness (23:00 to 00:00) from d 1 to d 7, followed by a schedule of 18 h light and 6 h darkness (23:00 to 05:00) until the end of the trial. All broilers were kept in floor pens with fresh wood shavings and received water and feed ad libitum. Inspection of the supply of water and feed, housing conditions, health status of the broilers and mortality was carried out daily. The same basal wheat-based diet was used for the three trials (Table S1). This diet did not contain fibre-degrading enzymes but did include phytase.

2.2.1. Control trial: caecal development and digesta particle size as a function of age

For the first trial, 44 broilers (Ross 308) at one day old were purchased from a commercial hatchery (Belgabroed NV, Merksplas, Belgium) and raised in one floor pen. At d 8, 15 and 36, a total of 18, 12 and 6 broilers, respectively, were sacrificed by electronarcosis followed by decapitation. The chyme and digesta of the gizzard, duodenum-jejunum, ileum (the section between Meckel’s diverticulum and ileocaecal intersect) and caeca were collected by gentle finger stripping of the segments and pooled per 3, 2 and 1 broilers on d 8, 15 and 36, respectively to obtain 6 replicate pools of digesta at each sampling age for further analysis. The caecal lobes and the ileocaecal intersect of each broiler were also collected. Digesta samples and caecal lobes were stored at -20 °C and the intersect at -80 °C until further analysis. The weight and length of the caecal lobes and the circumference of the caecal entrance (using a ruler) were measured during sampling.

2.2.2. Cellulose bead trial (large solid marker)

For the second trial, 176 male broilers (Ross 308) at one day old were purchased from a commercial hatchery (Belgabroed NV, Merksplas, Belgium) and randomly divided over 4 floor pens. Each pen was assigned to one dietary treatment and contained 44 broilers. The dietary treatments consisted of the basal wheat-based diet (Table S1) supplemented with 1% microcrystalline cellulose beads (Cellets®, Ingredientpharm, Pratteln, Switzerland) of one of 4 different particle sizes: 100, 200, 300, and 700 μm. At d 8, 15, 25 and 36, a total of 18, 12, 6 and 6 broilers, respectively, per dietary treatment were sacrificed by electronarcosis followed by decapitation. Digesta was pooled per 3, 2, 1 and 1 broilers on d 8, 15, 25 and 36 respectively to obtain 6 replicate pools of sufficient digesta at each sampling age for further analysis. Digesta collection and measurement on the caecal lobes were executed as described for the control trial (2.2.1).

2.2.3. Fluorescent polystyrene beads (small solid marker) and Cr-EDTA (soluble marker) trial

For the third consecutive trial, a total of 105 male broilers (Ross 308) at one day old were purchased from a commercial hatchery (Belgabroed NV, Merksplas, Belgium) and randomly divided over floor pens. On d 9 and d 29, a marker bolus of 1 mL was administered through oral gavage to 70 and 35 broilers, respectively. The bolus administration started in the morning, resulting in an administration starting time 9 or 4 h after the dark period at d 9 or d 29, respectively. No fasting period was applied beforehand to ensure conventional bowel movements, caecal filling and transit time. The bolus contained the soluble marker Cr-EDTA (954 μL/mL) and three types of solid fluorescent polystyrene microbeads (Spherotech™, Gentaur, Kampenhout, Belgium) with average particle sizes (D50) of 5 μm (1%, wt/vol), 15 μm (0.2%, wt/vol) and 30 μm (1%, wt/vol) with a concentration of respectively 9, 9 and 26 μL/mL in the bolus. On d 9 and d 29, respectively, 14 and 7 broilers per time point were sacrificed by electronarcosis followed by decapitation at 1, 3, 5, 10 and 24 h after the bolus administration to collect 7 replicate digesta pools per time point. At d 9, digesta was pooled per two broilers to obtain a sufficient amount for further analysis. Chyme and digesta of the gizzard, duodenum-jejunum, ileum (the section between Meckel’s diverticulum and ileocaecal intersect) and caeca were collected by gentle finger stripping the segments. The digesta and the emptied parts of the GIT were stored at -20 °C until further analysis.

2.3. Measurements on intestinal and digesta samples of the control trial

2.3.1. Microscopic visualisation of the caecal entrance

The tissue of the caecal entrance was embedded according to an adjusted method of Chen et al. (2002). Sections of the caecal entrance of each sampling age (d 8, 15, 36) were fixed in a 3.0% paraformaldehyde-1.0% glutaraldehyde solution for 16 h, after which they were washed with saline solution (0.9%) and cut into 5-mm tissue slices with a scalpel to obtain minimally 2 slices per caecal entrance. The tissue slices were dehydrated in ethanol series with increasing concentration (70% to 100%), cleared with toluene (99.8%), and then embedded in paraffin. These paraffin blocks were cut into 8-μm thick sections with a Leica RM2255 microtome (Leica Biosystems Nussloch GmbH, Nussloch, Germany). Sections were subsequently stained with hematoxylin (6 min) and eosin (30 s) for histological analysis. Dimensions of the caecal opening were measured using light microscopy (Nikon Eclipse 80i microscope, Nikon Inc., New York, USA) and ImageJ.

2.3.2. Determination of diet, ileal and caecal digesta particle size distribution

The particle size distribution of the diets (starter, grower, finisher) and of the ileal and caecal digesta at each sampled age (d 8, 15, 36) was measured with a Laser Diffraction Particle Size Analyzer LS 13 320 (Beckman Coulter Inc, Indianapolis, IN, USA). This device can measure particle sizes ranging from 0.375 to 2000 μm and assumes that all particles are spherical to generate a volumetric particle size distribution. Diets and ileal digesta were sieved through a 1000-μm mesh prior to this analysis due to technical restrictions (i.e. limit in particle size range) of the device. The volumetric D50 was also calculated for each measurement.

2.4. Detection and quantification of markers in digesta samples

2.4.1. Quantification of cellulose beads (large solid marker)

Ileal and caecal digesta samples of d 8, 15, 25 and 36 of broilers fed the diets enriched with cellulose beads were microscopically screened for the presence of the beads. Prior to bead screening, digesta samples were diluted as follows: 0.2 mL of caecal digesta (50.0 mg) of each replicate pool was diluted in 2.0-mL demineralised water in triplicate. Then, 0.2 mL of these solutions was placed on a microscopy glass to screen for cellulose beads. This microscopic screening was performed in triplicate for each solution to determine the presence of 100, 200 and 300 μm beads (10× magnitude, Nikon Eclipse 80i microscope, Nikon Inc., New York, USA). Due to the large size of the 700 μm beads, their presence was determined by visually screening the diluted digesta samples.

2.4.2. Detection of fluorescent polystyrene beads (small solid marker)

The collected digesta samples were screened for the presence of fluorescent polystyrene beads in collaboration with the Roeffaers Lab (KU Leuven, Belgium). After lyophilisation and grinding of ileal and caecal digesta samples of broilers that received the marker bolus, 50 mg digesta of each sample was suspended in 1 mL demineralised water. 250 μL of this solution was mixed with 250 μL agar and poured into a 9.4 mm × 10.7 mm × 9.3 mm well of an Ibidi μ-Slide 8 well for visualisation with a Leica TCS SP8X (Leica Microsystems GmbH, Germany). Three excitation and emission wavelength combinations were used simultaneously to detect the fluorescent polystyrene beads based on the optimal excitation and emission wavelength ranges of each bead type (wavelengths provided in Supplementary Table S2). Tile scans of the complete wells were made by capturing images of 517μm × 517 μm and a z-section depth of 1.2 μm (405 nm excitation) or a z-section depth of 1.7 μm (590 nm excitation) with a 10x magnification objective lens using Leica Application Suite X software (LAS X, Leica Microsystems GmbH, Germany). Image processing and bead counting was done through LAS X software and ImageJ, after which the number of beads on each image was summed to obtain a total bead count per tile scan and digesta replicate pool. Seven replicate pools of ileal and caecal digesta samples of d 8 and 25 of the control trial (2.1.1) were utilised in this analysis as control samples to validate the described bead detection method.

2.4.3. Quantification of Cr-EDTA (soluble marker)

Ileal and caecal digesta samples of broilers that received the marker bolus were lyophilised, ground, and subjected to an acid closed vessel digestion. Two reference samples of 100 mg Beech BR100 and three negative controls were included in each analysis. Eight milliters HNO3 (69%) was added to digesta samples (100 mg) of each replicate pool of both ages (d 9 and d 29). After a predigestion of 30 min, the samples were digested in a MARS 6 microwave (CEM, Matthews, North Carolina, United States) in closed MARSXpress Teflon tubes for 70 min at 180 °C (including 25 min warm-up and 25 min cool-down time). Next, 42-mL Milli-Q water was added to each digested sample. The samples were further diluted 4-fold with Milli-Q water, after which the solubilised Cr was measured through inductively coupled plasma spectrometry (ICP-MS, Agilent 7700x, Agilent Technologies, Santa Clara, California, United States). This resulted in an ileal and caecal Cr concentration (mg Cr/kg dry digesta) per replicate, which was converted to the total Cr content in the ileum and caeca based on the total digesta dry weight collected per replicate during sampling. The percentage of Cr found in the caeca compared to the total administered Cr in the bolus was also calculated.

2.5. Statistical analysis

Statistical analyses were performed using JMP Pro 16 Software and R Statistical Software (v4.0.5; R Core Team 2021). The normality of all datasets was evaluated through a density plot and quantile-quantile plot. The means of full caecal lobe weight, lobe length and caecal entrance diameter were calculated using sample sizes of 18, 12 and 6 broilers, respectively, at d 8, 15 and 36, due to the limited digesta sample size available from the younger birds. Broilers that showed signs of intestinal disease were excluded from this dataset. Significant differences in the mean full caecal lobe weight, lobe length and D50 of caecal digesta (n = 6) between age groups were identified by performing a one-way ANOVA and significantly different means were further identified using a Tukey’s test. Differences between mean caecal entrance diameter and cellulose bead counts in digesta (n = 6) were identified using a Wilcoxon Rank Sum test due to the non-normality of the data. Significant differences between mean total fluorescent bead counts in ileal and caecal digesta of the treated broilers compared to the control broilers (n = 7) were identified by performing a one-way ANOVA and significantly different means were further identified using a Student’s t-test. Significant differences in mean ileal and caecal Cr concentrations between the measured time points and in ranges of caecal influx ratio of Cr at different broiler ages (n = 7) were identified using the Wilcoxon Rank Sum test. Differences between means were considered significant at P < 0.05 and interpreted as a trend at 0.05 ≤ P ≤ 0.10.

3. Results

3.1. Control trial: caecal development and digesta particle size as a function of age

3.1.1. Development of caecal lobes and entrance as a function of age

The evolution of caecal lobe weight, length and circumference of the caecal entrance measured on fresh caecal lobes are shown in Fig. 1. The average weight of both full caecal lobes increased with age from 1.58 g (± 0.40) on d 8 to 12.18 g (± 5.25) on d 36 (P < 0.001). This corresponded to a relative weight of 0.87 g/100 g (± 0.30) BW on d 8 and 0.46 g/100 g (± 0.20) BW on d 36. The average length of the caecal lobe increased from 7.1 cm (± 0.7) on d 8 to 17.6 cm (± 2) on d 36 (P < 0.001). The average diameter of the caecal entrance measured on fresh samples increased from 0.2 cm (± 0.04) on d 8 to 0.4 cm (± 0.05) on d 36 (P < 0.001). Fig. 2 shows the stained sections of the embedded caecal entrances at d 8, 15 and 36. The visualisation of the caecal entrance showed that the true inner diameter of the entrance is markedly reduced due to additional tissue layers inside this entrance at all studied ages. These tissue layers consist of a submucosa layer with protrusions towards the inside of the caeca, on which a villi layer is attached. The average of the geometric mean diameters of the embedded caecal entrances measured 0.1133 cm (± 0.0224), 0.1943 cm (± 0.0457) and 0.2143 cm (± 0.0679) on d 8, 15 and 36, respectively.
Fig. 1

Fig. 1. Violin plots of the length (A), entrance diameter (B) and full weight (C) of fresh caecal lobes of the control trial measured during sampling at d 8 (n = 18), d 15 (n = 12) and d 36 (n = 6). Dots represent the mean value per age, vertical lines represent the Q1 to Q3 boxplot quantiles. Different letters indicate a significant difference between mean values of age groups (P < 0.05).

Fig. 2

Fig. 2. Microscopic images of 8-μm thick sections of caecal entrance tissue embedded in paraffin and stained with hematoxylin and eosin, from caecal lobes of the control trial collected at d 8 (A, B, C), d 15 (D, E, F) and d 36 (G, H, J). The muscular outer layers are stained in light pink, the inner submucosa and villi network are dark purple.

3.1.2. Ileal and caecal digesta particle size distribution as a function of age

The average diet, ileal and caecal particle size distribution of broilers fed a wheat-based diet as a function of age is shown in Fig. 3. There was a significant reduction in particle size as digesta moved from the ileum to the caeca at all studied ages. The D50 of the ileal digesta on d 8, 15 and 36 was 451 μm (± 49), 322 μm (± 25) and 409 μm (± 24), respectively, in comparison to the diameters of the caecal digesta of 5 μm (± 3), 9 μm (± 2) and 19 μm (± 8) at the same age. The D50 of the caecal digesta on d 8 was smaller than on d 36 (P < 0.001). On d 8 and d 15, 70% of the caecal digesta particles were smaller than 10 μm. On d 36, this upper limit for 70% of the particles increased to 30 μm. However, particles up to 400 μm were also present in caecal digesta of d 8. The geometric mean diameters of the caecal entrance (1133 to 2143 μm) vastly exceeded the caecal digesta D50 (5 to 19 μm) at every studied age.
Fig. 3

Fig. 3. Average volumetric particle size distribution of the diets, ileal and caecal digesta of the control group collected at d 8, 15 and 36 (n = 3 for each diet, n = 6 per age group for digesta), expressed as volume percentage. Orange lines represent the diets, blue lines the ileal digesta and green lines the caecal digesta. Dotted, dashed and solid lines represent the particle size distribution at an age of respectively 8, 15 and 36 d.

3.2. Detection and quantification of markers

3.2.1. Detection and quantification of cellulose beads (large solid marker)

All sizes of cellulose beads were found intact in the feed, along the GIT and in the excreta, demonstrating their inertness and suitability as particle size markers in broilers (Fig. S1). Individual body weight and gut development parameters were also not significantly affected by the inclusion of the cellulose beads. Fig. 4 shows the cellulose bead concentration in the caecal digesta for each screened replicate pool per age and per bead size. All sizes of cellulose beads (100 to 700 μm) were detected in at least one replicate pool at all studied ages (d 8 to 36), although the bead concentration in the caeca markedly varied between the replicate pools. A tendency towards higher bead concentrations at d 8 compared to d 36 could be observed irrespective of bead size, and this age effect was significant for the 100 μm and 300 μm beads (P < 0.001). As the bead count per gram of beads differed for each bead size (Table S2), the bead concentrations in digesta could not be compared directly between the different bead sizes. The ratio of the bead concentration in the caeca over that in the ileum is also shown in Fig. 4 per age group and bead size. This ratio indicates the caecal influx of the beads and ranged from 0.6% to 55.9% over all treatments and ages, showing large variability between biological replicates. The ratio was not affected by bead size or broiler age.
Fig. 4

Fig. 4. Beeswarm plots showing the effect of bead size (A: 100 μm [1739 beads per g feed], B: 200 μm [1089 beads per g feed], C: 300 μm [556 beads per g feed], D: 700 μm [55 beads per g feed]) on bead concentration in caecal digesta of broilers at different ages (d 8, 15, 25 and 36, n = 6 per age group). Points represent the bead count per g digesta of each biological replicate and a horizontal line indicates the average bead count per g digesta per age. Different letters indicate a significant difference in mean bead concentration between age groups (P < 0.05). Above each beeswarm, the ratio of bead concentration in the caeca compared to the ileum is given per bead size and age.

3.2.2. Detection and quantification of fluorescent polystyrene beads (small solid marker)

The total count of fluorescent polystyrene beads of 5 μm in digesta of the treated broilers 1 h after bolus administration only differed from the control broilers for the ileal digesta samples at the youngest age (d 9) (P < 0.001), as shown in Fig. 5. No significant differences in ileal (d 29) and caecal (d 9 and d 29) counts of 5 μm beads between the treated broilers and the control were detected. The low concentrations of the beads in the administered bolus, especially of the 15 μm and 30 μm beads due to their larger particle size, hindered their detection in all types of digesta samples. Strong autofluorescence signals of other digesta particles were observed in both the control and bead-treated ileal and caecal digesta samples, which further complicated the detection of the beads (Fig. S2 and Fig. S3).
Fig. 5

Fig. 5. Boxplots of total counts of 5-μm fluorescent polystyrene beads per tile scan by ImageJ for ileal digesta on d 9 (A), ileal digesta on d 29 (B), caecal digesta on d 9 (C) and caecal digesta on d 29 (D) of broilers 1 h after bolus administration compared to control broilers (n = 7 per age group). Different letters indicate a significant difference in mean bead count between treatments (P < 0.05).

3.2.3. Detection and quantification of Cr-EDTA (soluble marker)

Fig. 6 shows the total Cr content in the ileal and caecal digesta over time at d 9 and d 29 for each replicate pool and the average per age and time point, starting 1 h after bolus administration. The first presence of Cr in the ileum and caeca was already observed 1 h after bolus administration on both d 9 and d 29. The ileal Cr content at this first time point was higher at d 9 compared to d 29 (P = 0.022), but this age effect disappeared at later time points in the ileum. In contrast, the caecal Cr content remained higher at d 9 compared to d 29 at time points 3 h (P = 0.001) and 5 h (P = 0.004). The maximal Cr content was observed 3 h after bolus administration in the ileum at both ages, while a first maximal caecal Cr content was observed at the 5 h time point for both ages. The Cr content in the caeca compared to the total administered Cr in the bolus ranged from 3.5% to 13.2% (d 9) and from 1.7% to 4.3% (d 29) at the 5 h time point, with higher values at a younger age (P = 0.004). Relatively large amounts of Cr were retained in the caeca for up to 24 h at both ages, with a large variation between biological replicate pools. The total Cr content in the ileal and caecal digesta 1 h and 3 h after bolus administration and the calculated caecal influx ratio are shown in Fig. 7. Due to the high variation in both ileal and caecal Cr content, the results are shown per replicate pool. The unexpected mortality of three broilers between the period of bolus administration and sampling resulted in 6, 5 and 6 replicate pools instead of 7 in Fig. 7 for the time points 1 h and 3 h (d 9) and 1 h (d 29), respectively. The ratio of the Cr content in the caeca compared to the ileum at the 1 h time point can indicate the caecal influx of Cr or the flow of Cr from the ileum into the caeca. This ratio varied greatly between replicate pools due to variations in both the ileal and caecal Cr content. The caecal influx ratio tended to increase with age from 0.3% to 4% on d 9 to 0.8% to 75% on d 29 (P = 0.055). One replicate pool on d 29 already had a higher Cr content in the caeca compared to the ileum at the 1 h time point, resulting in a caecal influx ratio above 100% (430%). At the 3 h time point, two replicate pools showed a caecal influx ratio above 100%.
Fig. 6

Fig. 6. Beeswarm plots of the total Cr content in ileal (A: d 9, B: d 29) and caecal (C: d 9, D: d 29) digesta collected at 1, 3, 5, 10 and 24 h after bolus administration at d 9 and d 29 (n = 7 per time point and per age group). Points represent the total Cr content (mg) per biological replicate and a horizontal line indicates the average per time point.

Fig. 7

Fig. 7. Dumbbell plots of the Cr content (mg) in caecal (black dots) and ileal (grey squares) digesta collected 1 and 3 h after bolus administration at d 9 (A, B) and d 29 (C, D) of each biological replicate, corrected for digesta dry weights (n = 5 to 7 per age group). The ratio of the Cr content in the caeca compared to the ileum per biological replicate is given as percentage above each measurement.

4. Discussion

The evolution of the broiler’s caeca and the caecal digesta particle size distribution with age were studied as a first step to reveal the physical restrictions of caecal influx. An overall increase in caecal dimensions with age was observed, such as the enlargement in caecal diameter, lobe length and full lobe weight from d 8 to d 36. This illustrates the rapid development of the caeca with age and can also indicate an increase in caecal influx of digesta and fermentation capacity with age (Svihus et al., 2013). The relative full caecal lobe weights and dimensions measured in this study correspond to previous findings in literature when broilers were offered a wheat-based diet (Bautil et al., 2021). The observed increase in caecal weights and dimensions could also be expected based on other studies that recorded caecal development with age in broilers and other young poultry species (AbuAli et al., 2019; Martínez et al., 2021). The sections of the embedded caecal entrances displayed a similar increase in diameter with age, but more importantly, showed that the actual inner diameter of the caecal entrance, relevant for digesta influx, is markedly reduced due to a network of submucosa protrusions and villi. Additional mucus layers can also be expected to be part of this network but were probably lost during the embedding procedure. The visualisation of this network supports the hypothesis that the numerous villi at the caecal entrance act as a filter for incoming digesta particles, as described by Clench & Mathias (1999), Fenna & Boag (1973) and Svihus et al. (2013). This filtering effect was further confirmed by the large shift in D50 from the ileal digesta (409 to 451 μm) to the caecal digesta (5 to 19 μm). The lack of difference between the diet and ileal digesta particle size is mainly due to the required pre-sieving step before laser diffraction analysis. The presence of the villous network at the caecal entrance also explains the large size gap between the measured outer diameter of the caecal entrance (0.2 to 0.4 cm) and the actual D50 of the digesta inside the caeca at all studied ages. The villous network already seemed to be developed in the first week after hatch, but its firmness could however greatly vary with age. It appeared to be more brittle and was harder to visualise in detail at d 8 compared to d 15 and d 36, which can indicate a decreased filtering capacity of the villous network at a younger age. However, the smaller size of the caecal entrance tissue on d 8 compared to d 15 and d 36 could also have increased the difficulty of the visualisation procedure in general. Nonetheless, it is clear that this villous network at the caecal entrance restricts digesta inflow at all studied ages.
Based on the increase in the caecal physiological parameters and the caecal digesta D50 with age, the size of digesta particles that can pass through the caecal filter can also be expected to increase with age. The actual particle size range that allows caecal influx as a function of age was assessed by means of solid and soluble markers in two consecutive broiler trials. The microcrystalline cellulose beads that were used as the large solid marker in this study seemed to be a suitable marker in the broiler’s GIT due to their inertness along the GIT and the absence of an effect on individual body weights and gut development parameters. As previously confirmed in other studies, the soluble marker Cr-EDTA also seemed to be a suitable marker due to its inertness and accurate detection in the digesta (Iji, 2007; Vergara et al., 1989). The first appearance of Cr in the ileum and the caeca in this study was already detected within 1 h after bolus administration. This fast transit of liquid markers to the small intestine corresponds to the report regarding early marker appearance in broilers and quail by Fenna & Boag (1973) and Vergara et al. (1989). The direct administration of the bolus into the crop through the oral gavage technique used in the current study may have additionally accelerated the passage of the markers to the other GIT parts compared to marker intake through regular feeding. The major fraction of Cr was found after 3 and 5 h respectively in the ileum and caeca, corresponding to the expected digesta transit times in these GIT parts (Svihus & Itani, 2019). However, at these later time points, which correspond to the expected time for digesta to reach the caeca, the caecal Cr content already exceeded the ileal Cr content in multiple broilers at d 9, indicating an accumulation of Cr in the caeca and an evacuation of ileal content. The frequency of caecal emptying in broilers is estimated to be every 2 to 8 h based on previous own research (data not shown). Based on these findings, the data from the 1 h time point seemed the most reliable in estimating the flow of markers from the ileum to the caeca, with a minimal effect of caecal accumulation or retention of the markers at d 9. The same time point was used at d 29 to allow a correct comparison between both ages. The caecal influx ratios at the 3 h time point are also shown in Fig. 7, but may already be affected by caecal emptying and accumulation that are still poorly understood. To study caecal marker retention, all time points were taken into account (Fig. 6). Following this reasoning, the detection of the fluorescent polystyrene beads was also performed on the digesta collected 1 h after bolus administration for the estimation of their caecal influx. These fluorescent polystyrene beads were used as small solid markers but seemed less suitable for this study, as only the 5 μm beads were detected in the ileal digesta on d 9 and no beads were detected in the caecal digesta. This mainly seems due to the low administered concentration of the beads (9 to 26 vol % of bead solutions in the bolus), regarding the limited amount of caecal influx of small particles and fluids measured in this paper and previous studies (Garçon et al., 2023; Vergara et al., 1989). In addition, the beads were difficult to detect in the digesta matrix due to their similar size to digesta particles and the interference of the autofluorescence of feed and digesta compared to the relatively low administered bead concentrations. Using higher bead concentrations in the oral bolus and fluorescent coatings that do not overlap with the autofluorescent signal of feed and digesta could improve their suitability as a marker for studies on the broiler’s caeca. Preliminary screening of the samples obtained at later time points than 1 h did not show a better detection of fluorescent beads and were hence not analysed for this marker type.
An overall low caecal influx ratio was observed for both the solid and soluble markers, although this ratio varied between replicate pools. The average caecal influx ratio of the cellulose beads was only 5%, with no significant effect of age or bead size. Despite this low influx, the presence of cellulose beads with particle sizes up to 700 μm in the broiler’s caeca is remarkable, given that only 1% to 15% of the caecal digesta particles of the unsupplemented broilers were larger than 100 μm, and no particles larger than 500 μm were detected. The cellulose beads, however, differ from other digesta particles and from the native cellulose already present in the feed due to their dense microcrystalline structure, spherical shape and smooth surface. This might have facilitated their caecal entry, for example, by pushing through the villous network instead of being withheld as expected for light, non-spherical digesta particles such as wheat bran. The wide range of the caecal influx ratio of the cellulose beads (2% to 56%) over the different replicate pools shows that a high caecal marker concentration of these beads could also be achieved. A similar broad caecal influx range with a high maximum was observed for the soluble marker (0.3% to 75%) 1 h after bolus administration. It is important to note that the reported influx ratios of the cellulose beads, administered through continuous feeding, can be an overestimation if the potential accumulation of markers in the caeca over time is considered (Svihus et al., 2013; Vergara et al., 1989). On the other hand, the caecal influx ratios of the soluble marker can be an underestimation as these were calculated based on marker contents measured 1 h after marker administration. Although using this 1 h data minimizes the effect of caecal emptying and accumulation, later time points are considered more biologically relevant regarding caecal transit time (Svihus & Itani, 2019). These later time points were taken into account when studying caecal retention of the markers, but were not suitable for the calculation of the caecal influx ratio as outlined above. Aside from the infrequent caecal emptying and the possible accumulation of material in the caeca, the inflow of material into the caeca is assumed to be non-continuous and can additionally complicate the measurement and interpretation of caecal influx. A vastly higher caecal influx ratio of the soluble marker compared to the solid marker could have been expected based on the reports by De Vries et al. (2014), Svihus et al. (2013) and Vergara et al. (1989), but was not observed in this study. The absence of this difference may be caused by a greater accumulation of the cellulose beads in the caeca due to their larger size which may facilitate their retention in the caeca once they have entered, and their administration through continuous feeding instead of through a single bolus as used for the soluble marker. Aside from the caecal influx ratio, the maximal Cr content found in the caeca compared to the total amount of administered Cr can indicate the extent to which the soluble digesta fraction can enter the caeca, which ranged from 1.7% to 13.2% in this study, 5 h after bolus administration. Although these values align with the few other studies that quantified caecal influx in broilers, the possible accumulation and infrequent filling and emptying of the caeca should be taken into account for a correct interpretation. It is described that caecal digesta dry matter accounts for 18% of the total excreted dry matter in broilers and that 9% to 35% of the orally administered soluble marker Co-EDTA was found in the caeca, depending on broiler age (Garçon et al., 2023; Son et al., 2002; Vergara et al., 1989). So, despite the non-continuous caecal inflow and outflow dynamics complicating the interpretation of the obtained marker data, this paper confirms that even the caecal influx of the liquid fraction seems very limited. Together with the results on caecal digesta particle size distribution, the current results suggest that a particle size of less than 100 μm is required to achieve maximal caecal access. Although larger particles have also been demonstrated to affect caecal fermentation and microbiota (Boguslawska-Tryk et al., 2015; De Maesschalck et al., 2019; Pourazadi et al., 2020; Vermeulen et al., 2017), these results indicate that they will only enter the caeca in very limited quantities. Hence, despite the use of different marker types and time points in this study, the exact quantification of the fraction of ileal digesta particles that can actually pass the caecal filter to enter the caeca is still hindered by the complex caecal filling and emptying mechanisms and the important role of broiler age. Aside from particle size, other physicochemical characteristics such as solubility, viscosity and molecular weight are also expected to affect the caecal entrance of digesta (Svihus et al., 2013). However, this study did highlight the importance of particle size for caecal influx and provides an indication of the particle size range allowing this caecal influx, within the studied size ranges of the used solid (100 to 700 μm) and soluble markers. These new insights can be of use to further improve the maximal fibre fermentation capacity in the caeca.
In addition to particle size, broiler age also seemed to be an important factor when studying the physical aspects of digesta influx into the caeca. The caecal concentration of 100-μm and 300-μm beads, the total caecal Cr content at time points 3 and 5 h and the maximal percentage of Cr in the caeca compared to the total administered Cr were all higher at a younger age (d 8 to 9) compared to an older age (d 29 to 36). This contradicts the observed increase in caecal dimensions and caecal digesta D50 with age, as well as the increase in the caecal influx of Cr with age as observed by Vergara et al. (1989). The ileal and caecal Cr contents as a function of time (Fig. 6) can indicate a two-sided effect of age on the transit time and retention time of this marker in the GIT. Firstly, the higher ileal Cr content at d 9 compared to d 29 1 h after bolus administration may imply that the precaecal transit time of this marker is shorter at d 9 compared to d 29. Secondly, the increased caecal Cr concentrations at a younger age can be due to the faster passage of liquid digesta material at a younger age as confirmed for the ileal data above, which was also seen by Vergara et al. (1989) for the total tract transit time of Cr-EDTA. However, these authors assigned this age effect to the increase of caecal influx with age, while the current study shows that the passage is already faster in the GIT parts prior to the caeca. Similar to the liquid Cr marker, the results of the cellulose beads show a tendency towards a higher caecal marker concentration at a young age compared to an older age. These higher caecal marker concentrations at a younger age compared to an older age could also be the result of a greater caecal retention of the marker in younger birds. Other studies have shown that digesta can remain in the caeca for longer than 12 or 24 h, leading to increased retention times of certain markers (Garçon et al., 2023; Hinton et al., 2000; Vergara et al., 1989; Warriss et al., 2004). This aligns with the high caecal Cr concentrations observed 24 h after bolus administration. In addition, a longer transit time of the cellulose beads in the GIT at a young age compared to an older age was observed in an extra transit time experiment (data not shown), which may also be attributed to greater caecal retention of this relatively large solid marker. This means that the increased marker concentrations at a young age compared to an older age can reflect their accumulation in the caeca and may indicate a more restricted caecal outflow early in life rather than a more restricted inflow at an older age. This more restricted outflow may result from less contractile activity of the caeca lobes in young birds, which can be related to the previously reported limited functioning of the caeca at a very young age. For example, Svihus et al. (2013) expect that the full fermentation capacity of the caeca is not reached before d 28, which is supported by observations of increased levels of fermentation products formed in the caeca with increasing broiler age (Fischer, 2003; Lee et al., 2017). The increase in fibre fermentation capacity with broiler age is also reported by Bautil et al. (2019), where increased solubilisation and fermentation of arabinoxylan was measured in broilers at 21 d compared to 10 and 5 d. In addition, the bacterial density in the caeca has been observed to increase rapidly from hatch until 7 d, after which the density remains the same up to 30 d (Apajalahti et al., 2004). Similarly, the caecal microbial composition was observed to vary significantly in the first weeks of life (d 1 to d 10) but stabilised from 11 days on (Van Der Wielen et al., 2002). So, the seemingly longer retention of substrates in the caeca of younger birds is possibly a physiological adaptation to the underdeveloped caecal fermentation capacity early in life. Despite the higher Cr content in the caeca at a younger age compared to an older age at time points 3 and 5 h, the caecal influx ratio of Cr calculated 1 h after bolus administration did increase with age from 0.3% to 4% on d 9 to 0.8% to 75% on d 29. This indicates a higher influx of the liquid fraction from the ileum into the caeca at an older age, if caecal accumulation of the marker can be neglected at the 1 h time point. This age effect correspond to the trend observed by Vergara et al. (1989) using the same marker. The caecal influx ratio of the cellulose beads was not affected by age, possibly due to the large biological variation, caecal accumulation of the beads over time or the different physiochemical characteristics of the beads compared to digesta particles as described above. In conclusion, the results indicate that caecal influx of the soluble fraction can increase with age, whereas the accumulation of both the solid and soluble fraction in the caeca seems greater at a young age (d 8 or 9) compared to an older age (d 29 or 36). This accumulation effect might be attributed to the underdeveloped caecal fermentation capacity very early in life. The addition of more accessible fibre adapted to the age-specific caecal fermentation capacity, especially at very young ages, might further improve the nutritious value of broiler feeds as the increased caecal retention time of substrates at this young age provides a longer period for potential microbial fermentation and thus enables a potentially beneficial evolution of the caecal microbiome.
The wide ranges of the caecal content and the caecal influx of both the solid and soluble markers demonstrate the high biological variation that seems to be inherent to studying the caecal influx mechanism in broilers. A possible cause is the complex caecal filling and emptying mechanism, which is still not fully understood. As the caeca are expected to fill and empty in cycles, it is possible that the asynchronisation of these cycles between broilers contributed to the biological variation measured during these types of marker studies despite the synchronised light regimes that were applied for all broilers in the current study (Clench & Mathias, 1999; Fenna & Boag, 1973). As the main objective of this research was to study the caecal influx mechanisms, no fasting was applied prior to the marker administration in the current trials, as this may introduce a caecal filling and emptying behaviour that is atypical of the normal circumstances in which broilers are commercially raised. However, fasting the broilers before marker administration may contribute to the synchronisation of the marker movements along the GIT. This is common practice when using (fluorescent) markers in animals and would also decrease the issue caused by digesta autofluorescence, improving the detection of the fluorescence polystyrene beads (Li et al., 2018; van der Sluis et al., 2009). Another strategy to increase the synchrony in feeding patterns and, thus, caecal cycles between broilers is the use of a restricted feeding regime instead of continuous feeding or the adjustment of the sampling time points to the light regime. Both fasting and restricted feeding can provoke important changes in bowel motility, which is believed to also affect caecal filling, emptying and transit time, and were therefore not applied in the current study (Son et al., 2002).

5. Conclusion

This study showed that the caecal dimensions and digesta D50 increase with broiler age, suggesting that the digesta particle size allowing caecal influx also increases with age. A dense villous network at the entrance of the caeca restricts the inflow of digesta coming from the ileum, which explains the strong decrease in D50 of caecal digesta compared to ileal digesta. The effect of broiler age on the caecal filtering mechanism could be seen in the increased caecal diameter and digesta D50 with age on the one hand, but also in the increased caecal retention of markers at a young age compared to an older age on the other hand. The studied caecal digesta particle size distribution and influx of solid and soluble markers suggest that the caecal influx of particles larger than 100 μm is very limited. The content of the soluble marker Cr-EDTA in the caeca was maximally 13.2% of the initial orally administered dose in this study, illustrating the strong restriction of caecal influx for both solubles and solids. The caecal concentration of all three marker types showed considerable biological variation, which can be due to asynchronised caecal cycles between broilers. The study of caecal influx of markers was further complicated by the infrequent caecal filling and emptying dynamics which are still not fully understood, and by the possible accumulation of the used markers in the caeca. The results of this study highlight the physical limitations of caecal influx dictated by initial particle size and broiler age. Hence, carefully selecting the physical properties of fermentable fibre in function of age might aid in further improving caecal fibre fermentation in broilers.
Paulien Vanderghinste: Writing – original draft, Visualization, Validation, Methodology, Investigation, Formal analysis, Conceptualization. An Bautil: Writing – review & editing, Supervision, Methodology, Conceptualization. Michael R Bedford: Writing – review & editing, Conceptualization. Gemma Gonález-Ortiz: Writing – review & editing, Conceptualization. Chris Lamberigts: Methodology, Investigation. Imran Aslam: Resources, Methodology, Investigation. Maarten Roeffaers: Resources, Methodology. Christophe M Courtin: Writing – review & editing, Supervision, Resources, Conceptualization

Declaration of Competing Interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, and there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the content of this paper.

Acknowledgements

Colleagues of the Laboratory of Food Chemistry and Biochemistry, the Nutrition & Animal Microbiota EcoSystems Laboratory and the Laboratory of Livestock Physiology are thanked for their helping hands during the broiler trials. Marie Huyskens is thanked for performing the ICP-MS measurements. Quinten Wouters is thanked for assistance with the Leica TCS SP8X microscope. Paulien Vanderghinste acknowledges the Research Foundation Flanders for a position as PhD fellow (SB3423N).

Appendix A. Supplementary data

Original source: Animal Nutrition, Available online 16 January 2025, https://doi.org/10.1016/j.aninu.2024.12.004
The following is the Supplementary data to this article: Download: Download Word document (8MB)

References

US20240350437A1 Patent on gamma-hydroxybutyrate compositions

Patents US20240350437A1 and US20240350438A1 – Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state – Google Patents relates to pharmaceutical compositions and systems designed to provide controlled and consistent drug release for oral administration. The invention addresses challenges associated with delayed or multi-stage drug delivery, particularly for active pharmaceutical ingredients (APIs) with complex absorption profiles or sensitivity to environmental factors like pH. More specifically, gamma-hydroxybutyrate (GHB) is employed as API. GHB is a drug from the group of sedatives that is approved for the treatment of narcolepsy with cataplexy in adults.

The core of the patent involves multiparticulate formulations, in which small spherical particles or granules are coated with APIs and polymers. These coatings are designed to modulate drug release rates, enabling gradual, sustained, or targeted delivery in the gastrointestinal tract. This technology is particularly useful for achieving precise therapeutic effects, minimizing dosing frequency, and reducing potential side effects caused by rapid drug release.

The document highlights advancements in coating techniques and the use of stabilizing agents to improve the integrity and functionality of the drug delivery system. It also discusses scalability and manufacturing efficiency, making these formulations suitable for large-scale production while maintaining consistency in dosage and performance.

Potential applications include treatments for chronic conditions or drugs that require precise dosing regimens. The invention provides flexibility in formulating for a range of APIs, allowing for customization to meet specific therapeutic needs. By enabling controlled drug release, the technology enhances medication adherence and efficacy, benefiting both patients and healthcare providers.

What is the role of MCC pellets as drug carrier of gamma-hydroxybutyrate compositions?

This patent US20240350437A1 focuses on an innovative approach to creating multiparticulate pharmaceutical formulations designed for oral administration. The patent introduces CELLETS® which are a key component of the drug delivery system. CELLETS® are small, uniform spherical particles made of inert microcrystalline cellulose (MCC), that act as carriers for active pharmaceutical ingredients (APIs). These particles provide an optimal surface for drug layering, facilitating precise drug release profiles. In this patent, these types of CELLETS® are applicable:

  • CELLETS® 90
  • CELLETS® 100
  • CELLETS® 127

The invention addresses challenges in achieving controlled drug release, particularly for APIs requiring multi-step or delayed absorption. By coating these MCC carriers with specific polymers and APIs, the system allows for tailored drug release at targeted points in the gastrointestinal tract. This is especially beneficial for drugs with narrow therapeutic windows or those sensitive to pH levels.

The patent emphasizes advancements in coating techniques and formulation stability, ensuring high reproducibility and efficient manufacturing processes. The resulting multiparticulate system supports dosage flexibility, reduced side effects, and improved patient adherence compared to conventional tablet or capsule forms.

The invention has implications for developing treatments for chronic conditions, where consistent and predictable drug release is critical. The application of CELLETS® in this context highlights their versatility and potential to enhance the efficacy and safety of oral drug delivery systems.

Document information

Document Type and Numbers:

  • (“Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state”).
  • US20240350438A1 (“Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state”).
Kind Code: A1

Inventors:

Julien Grassot, Cendrine Grangeon, Jordan Dubow

Disclaimer

This text was partly generated by chatGPT engine version GPT‑4o, on Nov 21, 2024. Image was generated with Adobe Firefly.

Cellets list of publication

Selected Scientific literature on MCC pellets

Please, find scientific literature on MCC pellets (CELLETS®), MCC spheres. This list is constantly updated and does not claim to be complete. If you are author, scientist or R&D specialist, please submit your present publication to us for improving the visibility.

List – Publications with MCC spheres, 2024

Research article
In vitro validation of colon delivery of vitamin B2 through a food grade multi-unit particle system
Wageningen Academic (2024), eISSN: 1876-2891; doi:10.1163/18762891-bja00045
R.E. Steinert, W. Sybesma, R. Duss, A. Rehman, M. Watson, T.C. van den Ende, E. Funda

Research article
Homogeneity and mechanical properties of orodispersible films loaded with pellets
Eur. J. Pharm. Biopharm. 2024, 114537; doi:10.1016/j.ejpb.2024.114537
K. Centkowska, M. Szadkowska, M. Basztura, M. Sznitowska

Patent
Extended-release compositions comprising atomoxetine
A1

Patent
Extended release compositions comprising pyridostigmine
A1

Research article
The development of an innovative method to improve the dissolution performance of rivaroxaban
Heliyon 2024, (10)12; doi:10.1016/j.heliyon.2024.e33162
M. Langner, F. Priese, and B. Wolf

Research article
Influence of Polymer Film Thickness on Drug Release from Fluidized Bed Coated Pellets and Intended Process and Product Control
Pharmaceutics 2024, 16(10), 1307; doi:10.3390/pharmaceutics16070945
M. Langner, F. Priese, and B. Wolf

Thesis
Characterization of dense granular flows using a continuous chute flow rheometer
Purdue University, School of Materials Engineering, West Lafayette, Indiana, posted on 2024-07-20, 03:12
Kayli Lynn Henry

Research article
The Increase in the Plasticity of Microcrystalline Cellulose Spheres’ When Loaded with a Plasticizer
Pharmaceutics (2024), 16(7), 945; doi:10.3390/pharmaceutics16070945
A. Paulausks, T. Kolisnyk, V. Mohylyuk

Research article
The development of an innovative method to improve the dissolution performance of rivaroxaban
Heliyon 10 (2024) e33162; doi:10.1016/j.heliyon.2024.e33162
E.A. Ozon, E. Mati, O. Karampelas, V. Anuta, I. Sarbu, A.M. Musuc, R.-A. Mitran, D.C. Culita, I. Atkinson, M. Anastasescu, D. Lupuliasa, M.A. Mitu

Thesis
Uniform and homogenous hot-melt coating in a Wurster fluidized bed
TUM School of Life Sciences der Technischen Universität München, 2024
B. M. Wörthmann

Thesis
Modelling the disintegration of pharmaceutical tablets: integrating a single particle swelling model with the discrete element method
University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, CMAC National Facility, 2024, Thesis identifier T16863
M. Soundaranathan

List – Publications with MCC spheres, 2023

Research article
Paediatric solid oral dosage forms for combination products: Improving in vitro swallowability of minitablets using binary mixtures with pellets
European Journal of Pharmaceutical Sciences (2023), 187, 106471; doi:10.1016/j.ejps.2023.106471
A. Avila-Sierra, A. Lavoisier, C. Timpe, P. Kuehl, L. Wagner, C. Tournier, M. Ramaioli

Research article
Continuous Manufacturing of Cocrystals Using 3D-Printed Microfluidic Chips Coupled with Spray Coating
Pharmaceuticals (2023), 16(8), 1064; doi:10.3390/ph16081064
A. Kara, D. Kumar 2, A.M. Healy, A. Lalatsa, and D.R. Serrano

Research article
High-Speed Tableting of High Drug-Loaded Tablets Prepared from Fluid-Bed Granulated Isoniazid
Pharmaceuticals (2023), 15(4), 1236; doi:10.3390/pharmaceutics15041236
V. Mohylyuk, and D. Bandere

Research article
The Effect of Design and Size of the Fluid‑Bed Equipment on the Particle Size‑Dependent Trend of Particle Coating Thickness and Drug Prolonged‑Release Profile
AAPS PharmSciTech (2023) 24, 93. doi:10.1208/s12249-023-02540-9
T. Brezovar, G. Hudovornik, M. Perpar, M. Luštrik, R. Dreu

Research article
Amorphous Solid Dispersions Layered onto Pellets—An Alternative to Spray Drying?
Pharmaceutics (2023) 15(3), 764. doi:10.3390/pharmaceutics15030764
M. Neuwirth, S.K. Kappes, M.U. Hartig, K.G. Wagner

Research article
Optimization of Fluidized-Bed Process Parameters for Coating Uniformity and Nutrient-Release Characteristics of Controlled-Release Urea Produced by Modified Lignocellulosic Coating Material
Agronomy (2023) 13(3), 725. doi:10.3390/agronomy13030725
A.M. Ali, B. Azeem, A.M. Alghamdi, K. Shahzad, A. Ahmad Al-Zahrani, M. Imtiaz Rashid, A. Binti Mahpudz, A. Jamil

Research article
Hydrodynamic behaviour of CELLETS® (Ph.Eur./USP) in a spouted bed using image processing method
Particuology (2023), 76, 101-112, doi:10.1016/j.partic.2022.07.009
J. Vanamu, A. Sahoo

List – Publications with MCC spheres, 2022

Research article
Product-Property Guided Scale-Up of a Fluidized Bed Spray Granulation Process Using the CFD-DEM Method
Processes (2022) 10(7), 1291. doi:10.3390/pr10071291
P. Kieckhefen, S. Pietsch-Braune, S. Heinrich

Research article
Influence of In Situ Calcium Pectinate Coating on Metoprolol Tartrate Pellets for Controlled Release and Colon-Specific Drug Delivery
Pharmaceutics (2022) 14(5), 1061. doi:10.3390/pharmaceutics14051061
P. Wanasawas, A. Mitrevej, N. Sinchaipanid

Research article
Delamination and wetting behavior of natural hot-melt coating materials
Powder Technology (2022) 404, 117443. doi:10.1016/j.powtec.2022.117443
B.M. Woerthmann, L. Totzauer, H. Briesen

Research article
A systematic approach for assessing the suitability of enteral feeding tubes for the administration of controlled-release pellet formulations
International Journal of Pharmaceutics (2022) 612, 121286. doi:10.1016/j.ijpharm.2021.121286
F. Karkossa, N. Lehmann, S. Klein

Research article
Spray-freeze-dried lyospheres: Solid content and the impact on flowability and mechanical stability
Powder Technology (2022) 411, 117905. doi:10.1016/j.powtec.2022.117905
A. Rautenberg, A. Lamprecht

Conference proceedings
Assessment of the effect of microcrystalline cellulose (MCC) spheres size on the flow via powder rheology
The FORGE, 2022 – pure.qub.ac.uk
V. Mohylyuk, R. Dattani

Research article
Solventless amorphization and pelletization using a high shear granulator. Part II; Preparation of co-amorphous mixture-layered pellets using indomethacin and arginine
European Journal of Pharmaceutics and Biopharmaceutics (2022) 181, 183-194. doi: 10.1016/j.ejpb.2022.11.011
K. Kondo, T. Rades

Research article
Solventless amorphization and pelletization using a high shear granulator. Part I; feasibility study using indomethacin
European Journal of Pharmaceutics and Biopharmaceutics (2022) 181, 147-158. doi: 10.1016/j.ejpb.2022.11.010
K. Kondo, T. Rades

Research article
Application of different models to evaluate the key factors of fluidized bed layering granulation and their influence on granule characteristics
Powder Technology (2022), 408:117737. doi: 10.1016/j.powtec.2022.117737
R. Maharjan, S. H. Jeong

Research article
Evaluation of gravitational consolidation of binary powder mixtures by modified Heckel equation
Powder Technology (2022), 408:117729. doi: 10.1016/j.powtec.2022.117729
P. Svačinová, O. Macho, Ž. Jarolímová, M. Kuentz, Ľ. Gabrišová and Z. Šklubalová

Research article
Integrated Purification and Formulation of an Active Pharmaceutical Ingredient via Agitated Bed Crystallization and Fluidized Bed Processing
Pharmaceutics (2022), 14(5)1058. doi: 10.3390/pharmaceutics14051058
M. W. Stocker, M. J. Harding, V. Todaro, A. M. Healy and S. Ferguson

List – Publications with MCC spheres, 2021

Research article
Correlating Granule Surface Structure Morphology and Process Conditions in Fluidized Bed Layering Spray Granulation
KONA Powder and Particle Journal (2021), DOI:10.14356/kona.2022016
M. Orth, P. Kieckhefen, S. Pietsch and S. Heinrich

Research article
Relative bioavailability enhancement of simvastatin via dry emulsion systems: comparison of spray drying and fluid bed layering technology
Eur J Pharm Biopharm (2021), S0939-6411(21)00353-2. doi: 10.1016/j.ejpb.2021.12.004
M. Pohlen, J. Aguiar Zdovc, J. Trontelj, J. Mravljak, M. G. Matjaž, I. Grabnar, T. Snoj and R. Dreu

Research article
A novel method for assessing the coating uniformity of hot-melt coated particles using micro-computed tomography
Powder Technology, Volume 378, Part A, 22 January 2021, Pages 51-59
B.M. Woerthmann, J.A. Lindner, T. Kovacevic, P. Pergam, F. Schmid, H. Briesen

List – Publications with MCC spheres, 2020

Research article
Material specific drying kinetics in fluidized bed drying under mechanical vibration using the reaction engineering approach
Advanced Powder Technology, Volume 31, Issue 12, December 2020, Pages 4699-4713
Soeren E. Lehmann, Tobias Oesau, Alfred Jongsma, Fredrik Innings, Stefan Heinrich

Research article
Simulation of pellet coating in Wurster coaters
International Journal of Pharmaceutics, Volume 590, 30 November 2020, 119931
Hamid Reza Norouzi

Research article
Quantification of swelling characteristics of pharmaceutical particles
International Journal of Pharmaceutics, Volume 590, 30 November 2020, 119903
Mithushan Soundaranathan, Pattavet Vivattanaseth, Erin Walsh, Kendal Pitt, Blair Johnston, Daniel Markl

Short communication
Introduction of the energy to break an avalanche as a promising parameter for powder flowability prediction
Powder Technology, Volume 375, 20 September 2020, Pages 33-41
Žofie Trpělková, Hana Hurychová, Martin Kuentz, Barbora Vraníková, Zdenka Šklubalová

Research article
Easy to Swallow “Instant” Jelly Formulations for Sustained Release Gliclazide Delivery
Journal of Pharmaceutical Sciences, Volume 109, Issue 8, August 2020, Pages 2474-2484
Simmi Patel, Nathan Scott, Kavil Patel, Valentyn Mohylyuk, William J. McAuley, Fang Liu

Research article
Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles
International Journal of Pharmaceutics, Volume 585, 30 July 2020, 119562
Nathan Scott, Kavil Patel, Tariro Sithole, Konstantina Xenofontos, Valentyn Mohylyuk, Fang Liu

Research article
Measuring segregation characteristics of industrially relevant granular mixtures: Part II – Experimental application and validation
Powder Technology, Volume 368, 15 May 2020, Pages 278-285
Alexander M. Fry, Vidya Vidyapati, John P. Hecht, Paul B. Umbanhowar, Julio M. Ottinoa, Richard M. Lueptow

Research article
Non-uniform drug distribution matrix system (NUDDMat) for zero-order release of drugs with different solubility
International Journal of Pharmaceutics, Volume 581, 15 May 2020, 119217
Matteo Cerea, Anastasia Foppoli, Luca Palugan, Alic Melocchi, Lucia Zema, Alessandra Maroni, Andrea Gazzaniga

Research article
Effects of humidity on cellulose pellets loaded with potassium titanium oxide oxalate for detection of hydrogen peroxide vapor in powders
Powder Technology, Volume 366, 15 April 2020, Pages 348-357
Maria H. Kastvig, Cosima Hirschberg, Frans W.J. Van Den Berg, Jukka Rantanen, Mogens L. Andersen

Research article
In-line particle size measurement and process influences on rotary fluidized bed agglomeration
Powder Technology, Volume 364, 15 March 2020, Pages 673-679
Marcel Langner, Ivonne Kitzmann, Anna-Lena Ruppert, Inken Wittich, Bertram Wolf

Research article
Recent advance in delivery system and tissue engineering applications of chondroitin sulfate
Carbohydrate Polymers, Volume 230, 15 February 2020, 115650
Jun Yang, Mingyue Shen, Huiliang Wen, Yu Luo, Rong Huang, Liyuan Rong, Jianhua Xie

Research article
Fixed-bed-column studies for Methylene blue removal by Cellulose CELLETS
Environmental Engineering and Management Journal, Volume 19 (2), March 2020, 269-279
Iulia Nica, Gabriela Biliuta, Carmen Zaharia, Lacramioara Rusu, Sergiu Coseri, Daniela Suteu

Research article
Optimization and tracking of coating processes of pellets with polyvinylpyrrolidone solutions in an acoustic levitator
Powder Technology, Volume 360, 15 January 2020, Pages 1126-1133
Doris L. Wong, Anna-Lena Wirsching, Kai Betz, Andreas Reinbeck, Hans-Ulrich Moritz, Werner Pauer

List – Publications with MCC spheres, 2019

Research article
Measurement of hydrogen peroxide vapor in powders with potassium titanium oxide oxalate loaded cellulose pellets as probes
AAPS PharmSciTech, Volume 21(1):3, 11 Nov 2019
Maria H. Kastvig, Johan P. Bøtker, Ge Ge, Mogens L. Andersen

Research article
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production of Oral Sustained-Release Liquid Medicines for Patients with Swallowing Difficulties
AAPS PharmSciTech, Volume 21(1):3, 11 Nov 2019
Valentyn Mohylyuk, Kavil Patel, Nathan Scott, Craig Richardson, Darragh Murnane, Fang Liu

Research article
Assessment of the effect of Cellets’ particle size on the flow in a Wurster fluid-bed coater via powder rheology
Journal of Drug Delivery Science and Technology, Volume 54, December 2019, 101320
Valentyn Mohylyuk, Ioanna Danai Styliari, Dmytryi Novykov, Reiss Pikett, Rajeev Dattani

Research article
Particle electrification in an apparatus with a draft tube operating in a fast circulating dilute spout-fluid bed regime
Particuology, Volume 42, February 2019, Pages 146-153
Wojciech Ludwig

Research article
Development and evaluation of budesonide-based modified-release liquid oral dosage forms
Journal of Drug Delivery Science and Technology, Volume 54, December 2019, 101273
Federica Ronchi, Antonio Sereno, Maxime Paide, Ismaël Hennia, Pierre Sacré, George Guillaume, Vincent Stéphenne, Jonathan Goole, Karim Amighi

Research article
Evaluation of in-line particle measurement with an SFT-probe as monitoring tool for process automation using a new time-based buffer approach
European Journal of Pharmaceutical Sciences, Volume 128, 1 February 2019, Pages 162-170
Theresa Reimers, Jochen Thies, Stefan Dietrich, Julian Quodbach, Miriam Pein-Hackelbusch

Research article
In vitro and sensory tests to design easy-to-swallow multi-particulate formulations
European Journal of Pharmaceutical Sciences, Volume 132, 30 April 2019, Pages 157-162
Marco Marconati, Felipe Lopez, Catherine Tuleu, Mine Orlu, Marco Ramaioli

Research article
Numerical study of the hydrodynamics of fluidized beds operated under sub-atmospheric pressure
Chemical Engineering Journal, Volume 372, 15 September 2019, Pages 1134-1153
Sayali Zarekar, Andreas Bück, Michael Jacob, Evangelos Tsotsas

Research article
Solidification of carvedilol loaded SMEDDS by swirling fluidized bed pellet coating
International Journal of Pharmaceutics, Volume 566, 20 July 2019, Pages 89-100
J. Mandić, M. Luštrik, F. Vrečer, M. Gašperlin, A. Zvonar Pobirk

Research article
Quantitative bin flow analysis of particle discharge using X-ray radiography
Powder Technology, Volume 344, 15 February 2019, Pages 693-705
Sanket Bacchuwar, Vidya Vidyapati, Ke-ming Quan, Chen-Luh Lin, Jan D. Miller

Research article
Adjustment of triple shellac coating for precise release of bioactive substances with different physico-chemical properties in the ileocolonic region
International Journal of Pharmaceutics, Volume 564, 10 June 2019, Pages 472-484>
Eva-Maria Theismann, Julia Katharina Keppler, Jörg-Rainer Knipp, Daniela Fangmann, Esther Appel, Stanislav N. Gorb, Georg H. Waetzig, Stefan Schreiber, Matthias Laudes, Karin Schwarz

Research article
The analysis of the influence of the normal restitution coefficient model on calculated particles velocities by means of Eulerian-Lagrangian approach
Powder Technology, Volume 344, 15 February 2019, Pages 140-151
Wojciech Ludwig, PaweƚPłuszka

Research article
Measurement of granule layer thickness in a spouted bed coating process via optical coherence tomography
Powder Technology, Volume 356, November 2019, Pages 139-147
Swantje Pietsch, Anna Peter, Patrick Wahl, Johannes Khinast, Stefan Heinrich

Research article
A novel method of quantifying the coating progress in a three-dimensional prismatic spouted bed
Particuology, Volume 42, February 2019, Pages 137-145
Swantje Pietsch, Finn Ole Poppinga, Stefan Heinrich, Michael Müller, Michael Schönherr, Frank Kleine Jäger

Research article
Development and evaluation of an omeprazole-based delayed-release liquid oral dosage form
International Journal of Pharmaceutics, Volume 567, 15 August 2019, 118416
Federica Ronchi, Antonio, Sereno, Maxime Paide, Pierre Sacré, George Guillaume, Vincent Stéphenne, Jonathan Goole, Karim Amighi

Research article
Influence of separation properties and processing strategies on product characteristics in continuous fluidized bed spray granulation
Powder Technology, Volume 342, 15 January 2019, Pages 572-584
Daniel Müller, Andreas Bück, Evangelos Tsotsas

List – Publications with MCC spheres, 2018

Short communication
Novel production method of tracer particles for residence time measurements in gas-solid processes
Powder Technology, Volume 338, October 2018, Pages 1-6
Swantje Pietsch, Paul Kieckhefen, Michael Müller, Michael Schönherr, Frank Kleine Jäger, Stefan Heinrich

Research article
The effect of administration media on palatability and ease of swallowing of multiparticulate formulations
International Journal of Pharmaceutics, Volume 551, Issues 1–2, 15 November 2018, Pages 67-75
Felipe L. Lopez, Terry B. Ernest, Mine Orlu, CatherineTuleu

Research article
Compressibility and tablet forming ability of bimodal granule mixtures: Experiments and DEM simulations
International Journal of Pharmaceutics, Volume 540, Issues 1–2, 5 April 2018, Pages 120-131
Josefina Nordström, Göran Alderborn, Göran Frenning

Research article
Effects of pharmaceutical processes on the quality of ethylcellulose coated pellets: Quality by design approach
Powder Technology, Volume 339, November 2018, Pages 25-38
Prakash Thapa, Ritu Thapa, Du Hyung Choi, Seong Hoon Jeong

Research article
Euler-Lagrange model of particles circulation in a spout-fluid bed apparatus for dry coating
Powder Technology, Volume 328, 1 April 2018, Pages 375-388
Wojciech Ludwig, Paweł Płuszka

Research article
Inline acoustic monitoring to determine fluidized bed performance during pharmaceutical coating
International Journal of Pharmaceutics, Volume 549, Issues 1–2, 5 October 2018, Pages 293-298
Allan Carter, Lauren Briens

Research article
Sifting segregation of ideal blends in a two-hopper tester: Segregation profiles and segregation magnitudes
Powder Technology, Volume 331, 15 May 2018, Pages 60-67
Mariagrazia Marucci, Banien Al-Saaigh, Catherine Boissier, Marie Wahlgren, Håkan Wikström

Conference abstract
Multiple unit mini-tablets: Content uniformity issues
International Journal of Pharmaceutics, Volume 536, Issue 2, 5 February 2018, Pages 506-507
Anna Kira Adam, Jörg Breitkreutz

Research article
Influence of gas inflow modelling on CFD-DEM simulations of three-dimensional prismatic spouted beds
Powder Technology, Volume 329, 15 April 2018, Pages 167-180
Paul Kieckhefen, Swantje Pietsch, Moritz Höfert, Michael Schönherr, Stefan Heinrich, Frank Kleine Jäger

Research article
A redispersible dry emulsion system with simvastatin prepared via fluid bed layering as a means of dissolution enhancement of a lipophilic drug
International Journal of Pharmaceutics, Volume 549, Issues 1–2, 5 October 2018, Pages 325-334
Mitja Pohlen, Luka Pirker, Matevž Luštrik, Rok Dreu

Review article
Overview of PAT process analysers applicable in monitoring of film coating unit operations for manufacturing of solid oral dosage forms
European Journal of Pharmaceutical Sciences, Volume 111, 1 January 2018, Pages 278-292
Klemen Korasa, Franc Vrečer

Research article
On the properties and application of beeswax, carnauba wax and palm fat mixtures for hot melt coating in fluidized beds
Advanced Powder Technology, Volume 29, Issue 3, March 2018, Pages 781-788
M.G. Müller, J.A. Lindner, H. Briesen, K. Sommer, P. Foerst

Research article
Novel hydrophilic matrix system with non-uniform drug distribution for zero-order release kinetics
Journal of Controlled Release, Volume 287, 10 October 2018, Pages 247-256
Matteo Cerea, Alessandra Maroni, Luca Palugan, Marco Bellini, Anastasia Foppoli, Alice Melocchi, Lucia Zema, Andrea Gazzaniga

Research article
Role of plasticizer in membrane coated extended release oral drug delivery system
Journal of Drug Delivery Science and Technology, Volume 44, April 2018, Pages 231-243
Pinak Khatri, Dipen Desai, Namdev Shelke, Tamara Minko

Research article
Evaluation of pellet cycle times in a Wurster chamber using a photoluminescence method
Chemical Engineering Research and Design, Volume 132, April 2018, Pages 1170-1179
Domen Kitak, Rok Šibanc, Rok Dreu

Research article
Influence of perforated draft tube air intake on a pellet coating process
Powder Technology, Volume 330, 1 May 2018, Pages 114-124
Matevž Luštrik, Rok Dreu, Matjaž Perpar

Research article
Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating
European Journal of Pharmaceutics and Biopharmaceutics, Volume 124, March 2018, Pages 13-27
Dolores R. Serrano, David Walsh, Peter O’Connell, Naila A. Mugheirbi, Zelalem Ayenew Worku, Francisco Bolas-Fernandez, Carolina Galiana, Maria Auxiliadora Dea-Ayuela, Anne Marie Healy


Research article

Research article
Mechanics of Pharmaceutical Pellets—Constitutive Properties, Deformation, and Breakage Behavior
Journal of Pharmaceutical Sciences, Volume 107, Issue 2, February 2018, Pages 571-586
Alexander Russell, Rok Šibanc, Rok Dreu, Peter Müller

List – Publications with MCC spheres, 2017

Research article
Production of composite particles using an innovative continuous dry coating process derived from extrusion
Advanced Powder Technology, Volume 28, Issue 11, November 2017, Pages 2875-2885
Fanny Cavaillès, Romain Sescousse, Alain Chamayou, Laurence Galet

Research article
Determination of the release mechanism of Theophylline from pellets coated with Surelease®—A water dispersion of ethyl cellulose
International Journal of Pharmaceutics, Volume 528, Issues 1–2, 7 August 2017, Pages 345-353
Jurgita Kazlauske, Maria Margherita Cafaro, Diego Caccavo, Mariagrazia Marucci, Gaetano Lamberti, Anna Angela Barba, Anette Larsson

Research article
In-line monitoring of multi-layered film-coating on pellets using Raman spectroscopy by MCR and PLS analyses
European Journal of Pharmaceutics and Biopharmaceutics, Volume 114, May 2017, Pages 194-201
Jin Hisazumi, Peter Kleinebudde

Research article
Analysis of pellet coating uniformity using a computer scanner
International Journal of Pharmaceutics, Volume 533, Issue 2, 30 November 2017, Pages 377-382
Rok Šibanc, Matevž Luštrik, Rok Dreu

Research article
Modeling of particle velocities in an apparatus with a draft tube operating in a fast circulating dilute spout-fluid bed regime
Powder Technology, Volume 319, September 2017, Pages 332-345
Wojciech Ludwig, Daniel Zając

Research article
UV imaging of multiple unit pellet system (MUPS) tablets: A case study of acetylsalicylic acid stability
European Journal of Pharmaceutics and Biopharmaceutics, Volume 119, October 2017, Pages 447-453
Anna Novikova, Jens M. Carstensen, Thomas Rades, Claudia S. Leopold

Research article
New hybrid CPU-GPU solver for CFD-DEM simulation of fluidized beds
Powder Technology, Volume 316, 1 July 2017, Pages 233-244
H.R. Norouzi, R. Zarghami, N. Mostoufi

Research article
A top coating strategy with highly bonding polymers to enable direct tableting of multiple unit pellet system (MUPS)
Powder Technology, Volume 305, January 2017, Pages 591-596
Frederick Osei-Yeboah, Yidan Lan, Changquan Calvin Sun

Research article
Synthesis and melt processing of cellulose esters for preparation of thermoforming materials and extended drug release tablets
Carbohydrate Polymers, Volume 177, 1 December 2017, Pages 105-115
Sanna Virtanen, Riku Talja, Sauli Vuoti

Research article
Downstream drug product processing of itraconazole nanosuspension: Factors influencing drug particle size and dissolution from nanosuspension-layered beads
International Journal of Pharmaceutics, Volume 524, Issues 1–2, 30 May 2017, Pages 443-453
Johannes Parmentier, En Hui Tan, Ariana Low, Jan Peter Möschwitzer

List – Publications with MCC spheres, 2016

Research article
In-line particle size measurement and agglomeration detection of pellet fluidized bed coating by Spatial Filter Velocimetry
Powder Technology, Volume 301, November 2016, Pages 261-267
Dimitri Wiegel, Günter Eckardt, Florian Priese, Bertram Wolf

Research article
Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers
European Journal of Pharmaceutical Sciences, Volume 92, 20 September 2016, Pages 156-162
Felipe L. Lopez, Alexandra Bowles, Mine Orlu Gul, David Clapham, Terry B. Ernest, Catherine Tuleu

Research article
Micropellet-loaded rods with dose-independent sustained release properties for individual dosing via the Solid Dosage Pen
International Journal of Pharmaceutics, Volume 499, Issues 1–2, 29 February 2016, Pages 271-279
Eva Julia Laukamp, Klaus Knop, Markus Thommes, Joerg Breitkreutz

Research article
Multivariate calibration of the degree of crystallinity in intact pellets by X-ray powder diffraction
International Journal of Pharmaceutics, Volume 502, Issues 1–2, 11 April 2016, Pages 107-116
Krisztina Nikowitz, Attila Domján, Klára Pintye-Hódi, Géza Regdon jr.

Research article
Towards improving quality of video-based vehicle counting method for traffic flow estimation
Signal Processing, Volume 120, March 2016, Pages 672-681
Yingjie Xia, Xingmin Shi, Guanghua Song, Qiaolei Geng, Yuncai Liu

Conference abstract
Multiple-unit orodispersible mini-tablets
International Journal of Pharmaceutics, Volume 511, Issue 2, 25 September 2016, Page 1128
Anna Kira Adam, Christian Zimmer, Stefan Rauscher, Jörg Breitkreutz

Research article
Asymmetric distribution in twin screw granulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 106, September 2016, Pages 50-58
Tim Chan Seem, Neil A. Rowson, Ian Gabbott, Marcelde Matas, Gavin K. Reynolds, AndyIngram

Research article
Measurement of particle concentration in a Wurster coater draft tube using light attenuation
Chemical Engineering Research and Design, Volume 110, June 2016, Pages 20-31
R. Šibanc, I. Žun, R. Dreu

List – Publications with MCC spheres, 2015

Research article
Two-dimensional particle shape analysis from chord measurements to increase accuracy of particle shape determination
Powder Technology, Volume 284, November 2015, Pages 25-31
D. Petrak, S. Dietrich, G. Eckardt, M. Köhler

Research article
Passive acoustic emission monitoring of pellet coat thickness in a fluidized bed
Powder Technology, Volume 286, December 2015, Pages 172-180
Taylor Sheahan, Lauren Briens

Research article
Tabletability Modulation Through Surface Engineering
Journal of Pharmaceutical Sciences, Volume 104, Issue 8, August 2015, Pages 2645-2648
Frederick Osei-Yeboah, Changquan Calvin Sun

Research article
Cellulose CELLETS as new type of adsorbent for the removal of dyes from aqueous media
Environmental Engineering and Management Journal, Volume 14, Issue 3, March 2015, Pages 525-532
Daniela Suteu, Gabriela Biliuta, Lacramioara Rusu, Sergiu Coseri, Gabriela Nacu

Research article
Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane
International Journal of Pharmaceutics, Volume 480, Issues 1–2, 1 March 2015, Pages 15-26
Sheng-Feng Hung, Chien-Ming Hsieh, Ying-Chen Chen, Cheng-Mao Lin, Hsiu-O Ho, Ming-Thau Sheu

Research article
Dry Coating Characterization of Coverage by Image Analysis: Methodology
Procedia Engineering, Volume 102, 2015, Pages 81-88
Olivier Lecoq, Fredj Kaouach, Alain Chamayou

Research article
Passive acoustic emissions monitoring of the coating of pellets in a fluidized bed—A feasibility analysis
Powder Technology, Volume 283, October 2015, Pages 373-379
Taylor Sheahan, Lauren Briens

List – Publications with MCC spheres, 2014

Research article
A New Apparatus for Real‐Time Assessment of the Particle Size Distribution of Disintegrating Tablets
Journal of Pharmaceutical Sciences, Volume 103, Issue 11, November 2014, Pages 3657-3665
Julian Quodbach, Peter Kleinebudde

Research article
In-line spatial filtering velocimetry for particle size and film thickness determination in fluidized-bed pellet coating processes
European Journal of Pharmaceutics and Biopharmaceutics, Volume 88, Issue 3, November 2014, Pages 931-938
Friederike Folttmann, Klaus Knop, Peter Kleinebudde, Miriam Pein

Research article
On-line monitoring of fluid bed granulation by photometric imaging
European Journal of Pharmaceutics and Biopharmaceutics, Volume 88, Issue 3, November 2014, Pages 879-885
Ira Soppela, Osmo Antikainen, Niklas Sandler, Jouko Yliruusi

Research article
Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients
International Journal of Pharmaceutics
Volume 460, Issues 1–2, 2 January 2014, Pages 228-233

Anna Kluk, Malgorzata Sznitowska

Research article
In-line monitoring of pellet coating thickness growth by means of visual imaging
International Journal of Pharmaceutics, Volume 470, Issues 1–2, 15 August 2014, Pages 8-14
Nika Oman Kadunc, Rok Šibanc, Rok Dreu, Boštjan Likar, Dejan Tomaževič

Research article
Optical microscopy as a comparative analytical technique for single-particle dissolution studies
International Journal of Pharmaceutics, Volume 469, Issue 1, 20 July 2014, Pages 10-16
Sami Svanbäck, Henrik Ehlers, Jouko Yliruusi

Research article
Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs
European Journal of Pharmaceutics and Biopharmaceutics, Volume 87, Issue 1, May 2014, Pages 107-113
Lieselotte De Smet, Lien Saerens, Thomas De Beer, Robert Carleer, Peter Adriaensens, Jan Van Bocxlaer, Chris Vervaet, Jean PaulRemon

Research article
Global monitoring of fluidized-bed processes by means of microwave cavity resonances
Measurement, Volume 55, September 2014, Pages 520-535
Johan Nohlert, Livia Cerullo, Johan Winges, Thomas Rylander, Tomas McKelvey, Anders Holmgren, Lubomir Gradinarsky, Staffan Folestad, Mats Viberg, Anders Rasmuson

List – Publications with MCC spheres, 2013

Research article
Water-mediated solid-state transformation of a polymorphic drug during aqueous-based drug-layer coating of pellets
International Journal of Pharmaceutics, Volume 456, Issue 1, 1 November 2013, Pages 41-48
Andres Lust, Satu Lakio, Julia Vintsevits, Jekaterina Kozlova, Peep Veski, Jyrki Heinämäki, Karin Kogermann

Research article
Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique
Journal of Pharmaceutical Investigation (2013), 43:333–342. doi: 10.1007/s40005-013-0077-0
H. A. Hazzah, M. A. EL-Massik, O. Y. Abdallah & H. Abdelkader

Research article
Development of high drug loaded pellets by Design of Experiment and population balance model calculation
Powder Technology, Volume 241, June 2013, Pages 149-157
Florian Priese, Bertram Wolf

Research article
Particle sizing measurements in pharmaceutical applications: Comparison of in-process methods versus off-line methods
European Journal of Pharmaceutics and Biopharmaceutics, Volume 85, Issue 3, Part B, November 2013, Pages 1006-1018
Ana F.T. Silva, Anneleen Burggraeve, Quenten Denon, Paul Van der Meeren, Niklas Sandler, Tom Van Den Kerkhof, Mario Hellings, Chris Vervaet, Jean Paul Remon, João Almeida Lopes, Thomas De Beer

Research article
Physical properties of pharmaceutical pellets
Chemical Engineering Science, Volume 86, 4 February 2013, Pages 50-60
Rok Šibanc, Teja Kitak, Biljana Govedarica, StankoSrčič Rok Dreu

Research article
Continuous pellet coating in a Wurster fluidized bed process
Chemical Engineering Science, Volume 86, 4 February 2013, Pages 87-98
N. Hampel, A. Bück, M. Peglow, E. Tsotsas

Research article
Study of the recrystallization in coated pellets – Effect of coating on API crystallinity
European Journal of Pharmaceutical Sciences, Volume 48, Issue 3, 14 February 2013, Pages 563-571
Krisztina Nikowitz, Klára Pintye-Hódi, Géza Regdon Jr.

Research article
The influence of rolling friction on the shear behaviour of non-cohesive pharmaceutical granules – An experimental and numerical investigation
European Journal of Pharmaceutical Sciences, Volume 49, Issue 2, 13 May 2013, Pages 241-250
Ann-Sofie Persson, Göran Frenning

Research article
Characteristics of pellet flow in a Wurster coater draft tube utilizing piezoelectric probe
Powder Technology, Volume 235, February 2013, Pages 640-651
Matevž Luštrik, Rok Šibanc, Stanko Srčič, Matjaž Perpar, Iztok Žun, Rok Dreu

Research article
Estimating coating quality parameters on the basis of pressure drop measurements in a Wurster draft tube
Powder Technology, Volume 246, September 2013, Pages 41-50
Matjaž Perpar, Matevž Luštrik, Rok Dreu, Stanko Srčič, Iztok Žun

Research article
Influence of Non-Water-Soluble Placebo Pellets of Different Sizes on the Characteristics of Orally Disintegrating Tablets Manufactured by Freeze-Drying
Journal of Pharmaceutical Sciences, Volume 102, Issue 6, June 2013, Pages 1786-1799
Ulrike Stange, Christian Führling, Henning Gieseler

List – Publications with MCC spheres, 2012

Research article
A density-based segmentation for 3D images, an application for X-ray micro-tomography
Analytica Chimica Acta, Volume 725, 6 May 2012, Pages 14-21
Thanh N. Tran, Thanh T. Nguyen, Tofan A. Willemsz, Gijsvan Kessel, Henderik W. Frijlink, Kees van der Voort Maarschalk

Research article
Attrition and abrasion resistance of particles coated with pre-mixed polymer coating systems
Powder Technology, Volume 230, November 2012, Pages 1-13
G. Perfetti, F. Depypere, S. Zafari, P. van Hee, W.J. Wildeboer, G. M. H. Meesters

Research article
New spout-fluid bed apparatus for electrostatic coating of fine particles and encapsulation
Powder Technology, Volume 225, July 2012, Pages 52-57
Roman G. Szafran, Wojciech Ludwig, Andrzej Kmiec

Research article
Particle size and packing characterization by diffuse light transmission
Particuology Volume 10, Issue 5, October 2012, Pages 619-627
Henrik Ehlers, Jyrki Heinämäki, Jouko Yliruusi

Research article
Dry Powder Coating in a Modified Wurster Apparatus
Procedia Engineering, Volume 42, 2012, Pages 437-446
W. Ludwig, R.G. Szafran, A. Kmiec, J. Dziak

Research article
Attrition strength of water-soluble cellulose derivative coatings applied on different core materials
Powder Technology, Volume 222, May 2012, Pages 71-79
Katarzyna Nienaltowska, Frédéric Depypere, Giacomo Perfetti, Gabrie M.H. Meesters, Frederik Ronsse, Jan G. Pieters, Koen Dewettinck

Research article
An experimental evaluation of the accuracy to simulate granule bed compression using the discrete element method
Powder Technology, Volume 219, March 2012, Pages 249-256
Ann-Sofie Persson, Göran Frenning

List – Publications with MCC spheres, 2011

Research article
Dry particle high coating of biopowders: An energy approach
Powder Technology, Volume 208, Issue 2, 25 March 2011, Pages 378-382
S. Otles, O. Lecoq, J. A. Dodds

Research article
A density based segmentation method to determine the coordination number of a particulate system
Chemical Engineering Science, Volume 66, Issue 24, 15 December 2011, Pages 6385-6392
Thanh T. Nguyen, Thanh N. Tran, Tofan A. Willemsz, Henderik W. Frijlink, Tuomas Ervasti, Jarkko Ketolainen, Kees van der Voort Maarschalk

Research article
Study of the preparation of a multiparticulate drug delivery system with a layering technique
Powder Technology, Volume 205, Issues 1–3, 10 January 2011, Pages 155-159
Krisztina Nikowitz, Péter Kása Jr., Klára Pintye-Hódi, Géza Regdon Jr.

Research article
Effect of annealing time and addition of lactose on release of a model substance from Eudragit® RS coated pellets produced by a fluidized bed coater
Chemical Engineering Research and Design, Volume 89, Issue 6, June 2011, Pages 697-705
Ulrich M. Heckötter, Anette Larsson, Pornsak Sriamornsak, Mont Kumpugdee-Vollrath

Research article
Suspension pellet layering using PVA–PEG graft copolymer as a new binder
International Journal of Pharmaceutics, Volume 412, Issues 1–2, 30 June 2011, Pages 28-36
L. Suhrenbrock, G. Radtke, K. Knop, P. Kleinebudde

Research article
In-line particle sizing for real-time process control by fibre-optical spatial filtering technique (SFT)
Advanced Powder Technology, Volume 22, Issue 2, March 2011, Pages 203-208
Petrak Dieter, Dietrich Stefan, Eckardt Günter, Köhler Michael

Research article
Flowability of surface modified pharmaceutical granules: A comparative experimental and numerical study
European Journal of Pharmaceutical Sciences, Volume 42, Issue 3, 14 February 2011, Pages 199-209
Ann-Sofie Persson, Göran Alderborn, Göran Frenning

List – Publications with MCC spheres, 2010

Research article
Labscale fluidized bed granulator instrumented with non-invasive process monitoring devices
Chemical Engineering Journal, Volume 164, Issues 2–3, 1 November 2010, Pages 268-274
Jari T. T. Leskinen, Matti-Antero H. Okkonen, Maunu M. Toiviainen, Sami Poutiainen, Mari Tenhunen, Pekka Teppola, Reijo Lappalainen, Jarkko Ketolainen, Kristiina Järvinen

Research article
X-ray micro tomography and image analysis as complementary methods for morphological characterization and coating thickness measurement of coated particles
Advanced Powder Technology, Volume 21, Issue 6, November 2010, Pages 663-675
Giacomo Perfetti, Elke Van de Casteele, Bernd Rieger, Willem J. Wildeboer, Gabrie M.H. Meesters

Research article
Granule size distribution of tablets
Journal of Pharmaceutical Sciences, Volume 99, Issue 4, April 2010, Pages 2061-2069
Satu Virtanen, Osmo Antikainen, Heikki Räikkönen, Jouko Yliruusi

Research article
New insights into segregation during tabletting
International Journal of Pharmaceutics, Volume 397, Issues 1–2, 15 September 2010, Pages 19-26
S. Lakio, S. Siiriä, H. Räikkönen, S. Airaksinen, T. Närvänen, O. Antikainen, J.Yliruusi

Short communication
Can encapsulation lengthen the shelf-life of probiotic bacteria in dry products?
International Journal of Food Microbiology, Volume 136, Issue 3, 1 January 2010, Pages 364-367
F. Weinbreck, I. Bodnár, M.L. Marco

Research article
Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 76, Issue 1, September 2010, Pages 138-146
A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beera

List – Publications with MCC spheres, 2009

Research article
Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads
European Journal of Pharmaceutical Sciences, Volume 37, Issue 1, 11 April 2009, Pages 1-10
Chon gFan, Rashmi Pai-Thakur, Wantanee Phuapradit, Lin Zhang, Hung Tian, Waseem Malick, Navnit Shah, M. Serpil Kislalioglu

Short communication
Raman spectroscopic investigation of film thickness
Polymer Testing, Volume 28, Issue 7, October 2009, Pages 770-772
T. Sovány, K. Nikowitz, G. Regdon Jr., P. Kása Jr., K. Pintye-Hódi

Research article
In vivo evaluation of the vaginal distribution and retention of a multi-particulate pellet formulation
European Journal of Pharmaceutics and Biopharmaceutics, Volume 73, Issue 2, October 2009, Pages 280-284
Nele Poelvoorde, Hans Verstraelen, Rita Verhelst, Bart Saerens, Ellen De Backer, Guido Lopes dos Santos Santiago, Chris Vervaet, Mario Vaneechoutte, Fabienne De Boeck, Luc Van Borteld, Marleen Temmerman, Jean-Paul Remon

Research article
Modulating pH-independent release from coated pellets: Effect of coating composition on solubilization processes and drug release
European Journal of Pharmaceutics and Biopharmaceutics, Volume 72, Issue 1, May 2009, Pages 111-118
Simon Ensslin, Klaus Peter Moll, Hendrik Metz, Markus Otz, Karsten Mäder

Research article
Dry Particle High-Impact Coating of Biopowders: Coating Strength
Particulate Science and Technology, Volume 27(4), 2009
S. Ötles, O. Lecoq, J. A. Dodds


Research article

Book
Formulation and Analytical Development for Low-Dose Oral Drug Products
John Wiley & Sons , inc. (2009), ISBN 978-0-470-05609-7
Jack Zheng (Editor)

List – Publications with MCC spheres, 2008 and earlier

Research article
Attrition strength of different coated agglomerates
Chemical Engineering Science, Volume 63, Issue 5, March 2008, Pages 1361-1369
B. van Laarhoven, S.C.A. Wiers, S.H. Schaafsma, G.M.H. Meesters

Research article
Direct Drug Loading into Preformed Porous Solid Dosage Units by the Controlled Particle Deposition (CPD), a New Concept for Improved Dissolution Using SCF-Technology
Journal of Pharmaceutical Sciences, Volume 97, Issue 10, October 2008, Pages 4416-4424
Ragna S. Wischumerski, Michael Türk, Martin A. Wahl

Research article
Optimisation of an enteric coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 69, Issue 3, August 2008, Pages 969-976
Nele Poelvoorde, Nathalie Huyghebaert, Chris Vervaet, Jean-Paul Remon

Research article
Dynamic rearrangement of disulfide bridges influences solubility of whey protein coatings
International Dairy Journal, Volume 18, Issue 5, May 2008, Pages 566-573
René Floris, Igor Bodnár, Fanny Weinbreck, Arno C. Alting

Research article
New insight into modified release pellets – Internal structure and drug release mechanism
Journal of Controlled Release, Volume 128, Issue 2, 4 June 2008, Pages 149-156
Simon Ensslin, Klaus Peter Moll, Kurt Paulus, Karsten Mäder

Research article
Development of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 61, Issue 3, October 2005, Pages 134-141
Nathalie Huyghebaert, An Vermeire, Pieter Rottiers, Erik Remaut, Jean Paul Remon

Research article
Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis
European Journal of Pharmaceutics and Biopharmaceutics, Volume 59, Issue 1, January 2005, Pages 9-15
Nathalie Huyghebaert, An Vermeire, Sabine Neirynck, Lothar Steidler, Eric Remaut, Jean Paul Remon

Research article
Liquid absorption capacity of carriers in the food technology
Powder Technology, Volume 134, Issue 3, 30 September 2003, Pages 201-209
Heidi Lankes, Karl Sommer, Bernd Weinreich

 

Homogeneity and mechanical properties of orodispersible films loaded with pellets

This article on homogeneity and mechanical properties of orodispersible films loaded with pellets was published on Oct 20 2024 on ScienceDirect.

Abstract

Orodispersible films (ODFs) have served as an emerging platform for the delivery of drugs in a convenient way. The production of ODFs with incorporated pellets may still be a challenging process due to problems to obtain proper homogeneity and deteriorating mechanical properties of the films with incorporated relatively big particles in high concentration. The goal of this work was to evaluate the possibility to achieve fast disintegrating ODFs with homogenously incorporated spherical granules without loss of required mechanical properties. Hypromellose films with incorporated placebo pellets (size 200 µm or 100 µm) in a content range of 20–45 % w/w were prepared by a solvent casting method. Planetary mixer (Thinky) was successfully applied for preparation of a homogeneous mass for casting. The suspended spherical solid particles caused dose and size dependent changes in the mechanical properties and disintegration behaviour of ODFs films, but only 100 µm pellets in concentration higher than 40 % reduced significantly the tear resistance. The films with the pellets disintegrated faster and the larger particles reduced the disintegration time by 60 %. Good homogeneity of pellets distribution, expressed as a number of the particles per unit area, was confirmed for films obtained with a gap height 500 or 800 µm.

Document information

Pellet materials

Pellets in two different sizes: CELLETS® 100 and CELLETS® 200, composed of 100% microcrystalline cellulose, were used as model spherical granules.

Authors

Katarzyna Centkowska, Martyna Szadkowska, Marta Basztura, Małgorzata Sznitowska

Source

published on Oct 20 2024 on ScienceDirect under CC BY 4.0 license.

The patent WO2019123269A1, titled Packaged modified release gamma-hydroxybutyrate formulations having improved stability presents innovative formulations and packaging methods designed to enhance the dissolution and chemical stability of gamma-hydroxybutyrate (GHB), a treatment for narcolepsy. Current GHB treatments, like XYREM®, require patients to wake up mid-sleep for a second dose, making this method cumbersome. This patent aims to develop a once-nightly, modified-release GHB form that maintains stability through advanced packaging, which controls relative humidity to ensure long-term effectiveness and prevent chemical degradation of GHB into gamma-butyrolactone (GBL).

Key Innovations:

  1. Modified Release Formulation: The patent includes an immediate and modified release component, both containing GHB or a pharmaceutically acceptable salt. The modified release form is designed to control the release of GHB over time, providing sustained therapeutic effects throughout the night without the need for a second dose. This formulation helps improve patient convenience and adherence to treatment.
  2. Stability Issues with GHB: GHB is highly hygroscopic and chemically unstable, which leads to degradation, especially in high humidity environments. Its instability results in the formation of GBL, a degradation product that reduces the drug’s effectiveness. The patent addresses these challenges by creating a formulation with stable dissolution profiles and chemical stability, even under stressful storage conditions (e.g., high temperature and humidity).
  3. Packaging Innovation: To further enhance the stability, the GHB formulations are packaged in a way that maintains a specific relative humidity range (29% to 54%) within the package. This careful control of humidity is crucial to prevent GHB from degrading into GBL. The packaging material has a low water vapor transmission rate, reducing moisture exposure and ensuring the drug remains stable over time.
  4. Hydrophobic Coating: The patent uses a hydrophobic coating (e.g., glyceryl tristearate, hydrogenated vegetable oil) and methacrylic acid copolymers for the modified release component. These coatings help control the release rate of GHB and protect it from moisture, ensuring a steady release and preventing premature degradation.
  5. Pharmaceutical Composition: The GHB composition in the patent includes varying ratios of immediate and modified release components. These compositions are tailored to provide a sufficient therapeutic dose while maintaining stability. The sizes of the particles and the specific formulation ratios (e.g., 40/60 to 60/40) are key factors in achieving the desired pharmacokinetics and release profiles.

The primary innovation lies in controlling the relative humidity within the packaging, alongside a modified release formulation with hydrophobic coatings to maintain the drug’s chemical stability and effectiveness. These advancements make GHB therapy more convenient by eliminating the need for a second nightly dose and addressing the stability challenges that have plagued previous formulations.

In this patent, CELLETS® play a crucial role as inert cores used in the formulation of modified release or the active or salts thereof. These starter spheres serve as carriers for the active ingredient by providing a surface for multi-layer drug layering. Their primary function is to ensure uniform drug distribution and control the release profile of GHB. The benefits include enhancing dissolution stability, maintaining the integrity of the dosage form over time, and helping to modulate the release rate of the drug for once-nightly dosing convenience. For these aspects, MCC starter sphere types where employed: CELLETS® 90, CELLETS® 100, CELLETS® 127. Glatt ProCell™ technique is used for spraying molten API.

Document information

Document Type and Number: (“Packaged modified release gamma-hydroxybutyrate formulations having improved stability”).
Kind Code: A1

Inventors:

Hervé GUILLARD

Disclaimer

This text was partly generated by chatGPT engine version GPT‑4o, on Oct 21, 2024. Image was generated with Adobe Firefly.

The patent application titled “Modified Release Gamma-Hydroxybutyrate (GHB) Formulations Having Improved Pharmacokinetics” (US20240148685) focuses on improving the delivery of GHB, a substance used for treating sleep disorders like narcolepsy, through modified-release formulations. The goal is to optimize GHB’s absorption, enhancing patient convenience and compliance by reducing the need for multiple nightly doses.

The key innovation in the patent is the use of CELLETS®, microcrystalline spheres often employed as a neutral core for drug layering. In this application, CELLETS® act as carriers for the active ingredient, allowing precise control over the release profile of GHB. These small spherical particles, made from microcrystalline cellulose, offer uniform size and high mechanical strength, ensuring consistent drug loading and a controlled release rate.

In this patent, the CELLETS® are coated with various layers of GHB and release-modifying agents, enabling a predictable and sustained release of the active substance. This modified release profile allows GHB to be administered in a once-nightly dose rather than requiring the patient to wake up for a second dose, which was a limitation with previous immediate-release formulations. This extended-release mechanism helps maintain stable plasma concentrations of GHB over an 8-hour period, improving both the efficacy of the treatment and patient compliance.

The innovation emphasizes addressing the shortcomings of existing GHB formulations by ensuring a better pharmacokinetic profile—particularly regarding absorption, bioavailability, and minimizing drug levels in the bloodstream after the therapeutic effect has been achieved. In this specific patent, the following MCC Sphere types are recommended: CELLETS® 90, CELLETS® 100, CELLETS® 127.

Document information

Document Type and Number: (“Modified release Gamma-Hydroxybutyrate formulations having improved pharmacokinetics”)
Kind Code: A1

Inventors:

Dubow, Jordan (Lyon, FR)
Guillard, Hervé (Villeurbanne, FR)
Mégret, Claire (Lyon, FR)
Dubuisson, Jean-françois (Lyon, FR)

Disclaimer

This text was generated by chatGPT engine version GPT‑4o, on Oct 21, 2024. Image was generated with Adobe Firefly.

The United States Patent Application US20240024263 focuses on methods of administering gamma-hydroxybutyrate (GHB) in combination with divalproex sodium (DVP), particularly for treating conditions like narcolepsy. The aim is to co-administer these drugs without altering their dosage or efficacy. The patent emphasizes how DVP affects GHB’s pharmacokinetics, allowing adjustments to minimize side effects while ensuring therapeutic benefits.

The role of CELLETS® in this patent is critical. CELLETS® are microcrystalline cellulose spheres used in drug formulations. They provide a stable, controlled-release matrix for GHB, ensuring consistent drug delivery over time. This controlled release minimizes fluctuations in drug concentrations, improving safety and efficacy. These MCC starter beads also help prevent interaction between GHB and DVP, ensuring that neither drug’s therapeutic effects are compromised.

By using CELLETS®, the formulation enhances the pharmacokinetic profile of GHB, ensuring a smoother and more predictable drug release. This innovation is crucial when GHB is administered alongside DVP, as it allows for better management of conditions like excessive daytime sleepiness or cataplexy, without significantly altering either drug’s profile.

In summary, this patent introduces an optimized co-administration strategy for GHB and DVP, with Cellets playing a pivotal role in achieving steady, controlled drug release and mitigating adverse drug interactions. This approach aims to improve the overall effectiveness and safety of treatment for sleep-related disorders. In this specific patent, the following MCC Sphere types are recommended: CELLETS® 90, CELLETS® 100 or CELLETS® 127. United States Patent Application US20240024263 seems as well to be a patent following the patent US11896572B2 wherein modified-release formulations are described.

Document information

Document Type and Number: (“Methods of administering gamma-hydroxybutyrate compositions with divalproex sodium”)
Kind Code: A1

Inventors:

Baek, Bong-Sook, Flamel Ireland Limited (Dublin, IE)

Disclaimer

This text was generated by chatGPT engine version GPT‑4o, on Oct 21, 2024. Image was generated with Adobe Firefly.

The patent US11896572B2, titled “Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics,” outlines a pharmaceutical formulation aimed at optimizing the release and therapeutic effectiveness of gamma-hydroxybutyrate (GHB), a drug used for narcolepsy treatment. The patent focuses on improving GHB’s pharmacokinetics by creating a modified release system that extends its action, reducing the need for frequent dosing and improving patient compliance.

The formulation includes both immediate-release and delayed-release particles, allowing for a controlled release of GHB. This combination ensures that a portion of the drug is rapidly released for quick onset, while the remaining is gradually released, providing sustained therapeutic effects over time. The goal is to provide 6 to 8 hours of sleep with just one bedtime dose.

A key aspect of the patent is the use of CELLETS® which are spherical microcrystalline cellulose particles that serve as a core for both immediate and delayed-release systems (pellet technologies). These CELLETS® are critical because they provide a stable, uniform platform for the drug’s release. For the immediate-release component, CELLETS® are coated with sodium oxybate and a binder (povidone). For the delayed-release part, CELLETS® are coated with additional polymers, such as methacrylic acid copolymers and hydrogenated vegetable oil, which control the release based on pH levels in the gastrointestinal tract. This dual-layer system ensures precise drug release timing, optimizing the treatment’s effectiveness and minimizing side effects like abrupt peaks in drug concentration.

The CELLETS® play a crucial role in maintaining particle size consistency, which is important for ensuring predictable dissolution and absorption rates, thereby enhancing the overall pharmacokinetic profile of the drug. This innovation represents an advancement over traditional formulations by offering more reliable and patient-friendly narcolepsy management. In this specific patent, the following MCC Sphere types are recommended: CELLETS® 90, CELLETS® 100 or CELLETS® 127.

By utilizing CELLETS® and other advanced components, the patent aims to reduce the frequency of administration (allowing for once-daily dosing) and improve patient compliance, which is especially important for MG patients who need consistent, long-term management of their symptoms.

Document information

Document Type and Number: (“modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics”)
Kind Code: B2

Inventors:

Jordan Dubow
Hervé Guillard
Claire Mégret
Jean-François DUBUISSON

Disclaimer

This text was generated by chatGPT engine version GPT‑4o, on Oct 21, 2024. Image was generated with Adobe Firefly.

Figure 3: SEM picture of cross section of a Taste masked pellets coated with 25 mg Eudragit EPO.

Abstract

This case study on Atomoxetine HCl pellets is a short abstract of the publication by Y.D. Priya et al. [1].

Atomoxetine is a medication used to treat attention deficit hyperactivity disorder (ADHD) [2]. The API is marketed under the trade names Atomoxetine, Atomoxe, Agakalin, and Strattera (initially launched) [3]. Atomoxetine is an extremely bitter API. As being initially launched for children as capsules or tablets, the paediatric compliance by improved taste-masking and the simplified administration to paediatrics are in focus of this study.

A multi-unit particulate pellet coating (MUPS) was selected as oral dosage form. The fluidized bed technology (with Wurster column) was employed for coating and layering processes. This is a well-known technology, which Is for instance offered by Glatt. Starter cores were coated with the API, followed by layering with a polymeric coating for which realized the taste-masking.

Atomoxetine layering

Starter cores are made of Microcrystalline Cellulose (MCC) in sizes comparable to CELLETS® 200, while a fair efficiency of drug layering was observed with the combination of HPMC (Hydroxypropyl methyl cellulose) and HPC (Hydroxypropyl cellulose) as binders. The composition of API layering is presented in Table 1. The drug dispersion was sprayed onto the MCC pellets with an inlet temperature between 50 °C and 55 °C and a fluidized bed temperature between 35 °C and 40 °C.

API layering material Composition
Starter core
  MCC pellets 58.00
API layering
  Atomoxetine HCl 25.00
  Hydroxypropyl methylcellulose 3.50
  Hydroxypropyl Cellulose 3.50
  Low-Substituted Hydroxypropyl Cellulose 5.00
  Talc 5.00
  Purified Water Qs
Total weight (mg) 100.00

Table 1: Formulation of API layered pellets.

Taste-masking coating

The polymeric taste-masking layer is made of a methacrylate co-polymer (Eudragit EPO) providing an excellent coating with taste masking properties for fine particles and tablets. The composition of the taste-masking suspension is shown in Table 2. The inlet temperature is between 40 °C and 45 °C, and fluidized bed temperature is between 25 °C and 30 °C.

Polymeric coating material Composition
Drug Layered pellets 100.00
Eudragit EPO 25.00
Sodium Lauryl Sulfate 2.500
Stearic acid 3.750
Talc 6.25
FD&C Yellow No. 6 0.50
FD&C Red No. 3 0.05
Purified Water Qs
Total weight (mg) 138.050

Table 2: Formulation of polymeric coating suspension.

The efficiency of taste-masking was benchmarked by a bitterness rating on human volunteers. Figure 1 shows, that the taste sensitivity identifies a bitterness at 6 µg/ml API concentration and an extreme bitterness at 7 µg/ml API and higher concentration. Thus, the threshold bitterness of Atomoxetine HCl is 6 µg/ml.

Atomoxetine: bitternessFigure 1: Concentration of drug solution (µg/ ml). Bitter intensity ratings from no bitterness (green), bitterness (blue), extremely bitter (red).

Figure 1: Concentration of drug solution (µg/ ml). Bitter intensity ratings from no bitterness (green), bitterness (blue), extremely bitter (red).

All the volunteers felt bitter taste when the drug layered pellets were coated with 6.25 mg of Eudragit EPO. Whereas in the pellets coated with 12.5 mg and 18.75 mg of Eudragit EPO, bitter taste was masked up to 15 seconds after keeping the tablet in the mouth, and later all the human volunteers felt bitter taste. When the concentration of Eudragit EPO was increased to 25 mg, the bitter taste of Atomoxetine HCl was completely taste-masked and no volunteer was felt bitter taste.

Figure 2: In-Vivo Taste evaluation in healthy human volunteers.

Figure 2: In-Vivo Taste evaluation in healthy human volunteers.

Figure 3 depicts the entire particle size of a taste-masked MCC pellet coated with the Atomoxetine drug layer and 25 mg of Eudragit EPO. The average particle size of the taste-masked pellets is between 180 µm and 250 µm, assuming, that no gritty feeling of particles in patient’s mouth will appear. It should be said, that a micronization of Atomoxetine HCl was deemed to be necessary for the drug layering process. Micronization minimized the surface roughness of the API layered pellet so that an efficient taste-masking coating can be applied.

Figure 3: SEM picture of cross section of a Taste masked pellets coated with 25 mg Eudragit EPO.

Figure 3: SEM picture of cross section of a Taste masked pellets coated with 25 mg Eudragit EPO.

Summary

MCC pellets in the size of about 200 µm were layered with Atomoxetine. HPMC and HPC were used as binders, realizing a precise surface definition for a subsequent taste-masking coating. The taste-masking was most efficient at a polymeric concentration of 25 mg. Keeping the size of the coated pellets below 300 µm avoids a gritty feeling and thus increase the patient’s compliance.

This study by Priya et al. indicated that the fluidized bed process produced the most appropriate taste masked pellets of Atomoxetine HCl for oral disintegrating tablets.

References

[1] Y.D. Priya et al., Int J Pharm Pharm Sci, (6) 7, (2014) 110-115

[2] “Atomoxetine Hydrochloride Monograph for Professionals”. Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 4 April 2019. Retrieved 22 March 2019.

[3] ROTE LISTE 2017, Verlag Rote Liste Service GmbH, Frankfurt am Main, ISBN 978-3-946057-10-9, (2017) 162.